rfhg_124652.1

Basic information about the TSS

---

TSS ID: rfhg_124652.1 Species: human Chr: chr10		Start: 33334899 End: 33334907 Strand: -
Source datasets	PRJNA4843412|DRA013844
Protocol	NETCAGE|CAGE
TSS cluster detected*	2

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2332615,EH38E1460941)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000395995.5:0 CR749333:0 GeneID: 8829 HGNC/MGI_ID: HGNC:8004 UniProt_ID: E9PEP6 Q68DN3 Nearer transcript ids and distances: BX648250:25 ENST00000432372.6:-171 BX648025:-171 ENST00000374867.7:232 NM_003873.7:232 NM_001330068.2:232 NM_001244972.2:232 NM_001244973.2:232 NR_045259.2:232 NM_001024628.3:232 NM_001024629.3:232 ENST00000374822.8:257 BC007533:257 ENST00000374875.5:263 AL833608:263 AK292822:328 BX510902:357 AB209641:368 ENST00000374821.9:377 ENST00000374816.7:377 BC007737:377 AF268691:377 view more...

Gene_name: NRP1 Gene_symbol: NRP1 Gene_synonyms: CD304 NRP VEGF165R Gene_source: HGNC:8004

TATA-Box annotation

---

Distance to TSS:	2
Nearest PromoterID:	NR_045259
Entrez ID:	8829
Nearest Unigene:	Hs.131704
Nearest Refseq:	NM_003873
Nearest Ensembl:	ENSG00000099250
Gene Name:	NRP1
Gene Alias:	BDCA4|CD304|NP1|NRP|VEGF165R
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.555556
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NRP1 p2@NRP1 p3@NRP1 p4@NRP1 p5@NRP1 p6@NRP1 p7@NRP1 p8@NRP1 p9@NRP1 p10@NRP1
Sample		p1@NRP1	p2@NRP1	p3@NRP1	p4@NRP1	p5@NRP1	p6@NRP1	p7@NRP1	p8@NRP1	p9@NRP1	p10@NRP1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	5.45	2.53	0.78	0.19	0.19	0.19	0.58	0.58	0.00	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	5.87	3.64	0.20	0.20	0.00	1.21	0.61	1.42	0.81	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	7.14	3.09	0.96	0.58	0.58	0.77	0.58	0.77	0.39	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	4.16	1.04	0.83	0.62	0.00	0.62	0.42	0.83	0.00	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	4.05	1.35	0.45	0.22	0.22	0.22	0.22	0.22	0.45	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	7.36	1.55	1.16	0.00	0.19	0.39	0.00	0.78	0.39	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	5.45	0.87	0.87	0.00	0.44	0.00	0.22	0.65	0.22	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	2.18	0.97	0.73	0.24	0.00	0.73	0.73	0.24	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	2.99	1.50	1.28	0.43	0.21	0.64	0.00	0.21	0.21	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	4.64	0.58	0.58	0.00	0.00	0.58	0.58	0.58	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	6.87	0.00	0.81	0.40	0.00	0.00	0.00	0.00	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	3.25	1.63	2.03	0.81	0.00	0.00	0.00	0.00	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	12.25	2.26	1.13	0.48	0.81	1.29	1.77	1.61	1.45	1.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	12.78	3.01	0.60	0.45	0.30	0.90	2.56	1.95	1.20	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	11.42	3.73	1.10	0.00	0.22	2.63	0.66	0.88	1.10	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	14.08	3.02	1.26	1.26	0.50	0.75	1.76	1.01	0.50	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	12.89	4.15	0.87	1.09	0.00	0.66	1.31	1.53	1.75	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	9.70	2.53	0.00	0.42	0.42	0.84	1.27	2.11	1.27	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	11.20	2.67	0.53	0.53	0.53	0.00	1.60	0.53	0.00	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	10.83	4.21	0.60	0.60	0.90	1.35	0.45	2.41	1.05	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	8.29	2.67	0.94	1.07	0.00	0.40	0.80	2.54	0.53	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	8.46	3.45	0.17	1.04	0.35	0.69	0.35	1.55	0.86	0.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	9.18	3.49	0.52	0.52	0.26	1.29	0.65	1.94	0.52	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	9.95	4.85	0.49	0.73	0.24	0.73	0.49	2.18	1.21	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	14.45	3.87	1.29	0.52	0.26	0.52	1.81	1.81	0.52	2.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	9.50	3.17	0.00	0.63	0.63	1.27	1.90	1.27	0.32	1.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	13.74	1.10	0.55	2.20	0.00	1.65	2.75	2.75	1.65	2.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	10.14	2.36	0.94	0.71	0.94	0.71	0.71	1.41	0.24	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	8.24	1.62	0.65	0.16	0.00	0.16	1.13	1.62	0.81	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	13.57	1.63	0.18	0.36	0.18	1.27	1.63	1.09	0.54	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	9.84	1.88	1.05	0.21	0.00	1.05	1.26	1.67	0.42	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	8.79	2.54	0.39	0.98	0.78	0.98	1.37	0.78	1.56	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	9.29	3.59	0.42	0.21	0.42	0.42	1.06	0.63	0.63	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	12.54	4.62	0.49	0.00	0.66	0.33	0.49	1.32	0.66	3.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	8.79	3.74	0.37	0.56	0.75	0.75	1.31	1.68	0.19	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	12.84	2.30	0.77	0.00	0.57	0.96	1.72	1.72	0.57	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	12.88	1.84	1.23	0.20	0.20	1.23	1.23	1.43	0.41	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	10.88	4.03	0.81	0.60	0.40	1.01	1.81	1.41	0.60	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	11.61	4.05	0.81	0.54	0.81	1.08	1.08	1.89	0.27	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	7.20	3.36	0.96	1.20	0.24	0.00	0.96	1.68	0.24	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	8.23	2.12	0.71	0.47	0.00	0.94	0.94	0.47	0.71	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	11.13	4.10	0.73	0.88	0.29	0.29	1.61	1.32	0.59	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	13.71	2.95	0.84	0.63	0.42	0.84	0.84	0.84	0.63	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	9.62	1.57	0.87	0.17	0.35	1.05	0.70	1.40	0.87	2.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	8.43	1.00	1.00	0.20	1.00	1.81	1.41	0.60	1.20	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	4.65	1.63	0.23	0.70	0.23	1.16	0.70	1.40	0.23	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	9.84	2.16	0.24	0.24	0.00	0.48	2.16	0.96	0.72	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	9.24	2.38	0.89	0.30	0.00	0.89	0.30	1.79	0.60	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	9.57	1.44	0.96	0.72	0.48	0.96	1.91	1.44	0.96	2.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	10.72	2.43	1.01	0.81	0.61	1.62	0.81	1.21	1.01	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	9.63	2.87	0.61	1.23	0.41	0.82	1.02	1.43	1.43	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	15.34	1.78	0.44	0.22	1.11	1.11	0.67	1.78	0.67	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	433.76	0.00	13.99	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	12.07	1.06	0.35	0.71	0.35	1.77	0.35	1.42	0.00	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	11.27	2.32	2.32	2.32	0.66	1.99	0.33	0.99	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	24.33	24.33	0.84	1.68	0.00	0.84	3.36	0.00	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	13.78	6.89	0.46	0.92	1.84	1.38	0.92	1.38	0.92	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	24.96	1.62	1.94	0.65	0.65	1.30	1.62	1.30	1.94	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	17.99	1.93	1.61	0.96	1.28	3.85	1.93	0.96	0.64	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	25.46	4.71	0.00	0.63	0.63	1.89	1.89	0.63	1.89	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	17.63	2.12	0.71	0.71	0.00	1.41	3.53	3.53	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	17.95	2.24	1.68	0.56	0.56	1.68	1.12	0.56	1.12	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	82.00	7.96	0.00	2.39	0.00	7.17	12.74	2.39	4.78	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	41.79	5.44	1.36	2.04	1.36	1.70	3.40	2.38	3.74	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	50.69	2.60	3.57	0.97	0.32	4.55	2.92	1.95	3.90	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	33.01	1.06	2.13	2.84	0.35	1.42	1.77	0.71	1.42	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	64.66	436.43	16.16	0.00	0.00	0.00	16.16	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	94.77	276.41	0.00	0.00	0.00	0.00	7.90	0.00	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	51.19	2.93	0.98	0.98	0.98	3.90	1.95	1.46	1.46	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	47.60	8.43	2.98	2.48	2.48	3.97	2.48	1.98	1.98	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	63.33	5.63	0.94	1.88	1.41	8.91	1.41	4.22	1.41	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	138.77	10.93	4.31	3.31	2.32	9.60	8.61	1.66	7.95	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	106.72	4.02	2.47	2.78	2.47	10.52	9.59	2.78	3.40	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	81.94	4.28	2.75	1.53	2.45	12.84	7.64	3.06	1.83	1.53
Adipocyte - breast, donor1	11376-118A8	13.15	23.92	18.37	13.78	10.29	2.69	0.63	1.27	1.74	0.63
Adipocyte - breast, donor2	11327-117E4	9.79	24.87	11.23	7.86	7.22	1.76	2.09	1.93	0.64	0.32
Adipocyte - omental, donor1	11473-119C6	19.08	20.74	27.23	9.80	10.94	2.42	2.29	1.40	2.29	0.38
Adipocyte - omental, donor2	11474-119C7	5.98	10.46	11.96	4.48	1.49	1.49	0.75	0.00	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	14.07	16.41	32.49	4.69	4.02	2.34	2.01	1.34	0.33	0.33
Adipocyte - perirenal, donor1	11476-119C9	3.19	8.29	5.74	3.19	0.64	0.00	0.64	0.64	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	1.10	3.30	3.30	1.10	2.20	0.00	0.00	0.00	1.10	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	13.10	20.77	15.36	7.23	5.42	1.81	0.90	0.45	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	9.21	10.60	13.55	8.52	13.55	1.04	1.04	0.70	1.39	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	70.99	49.09	55.35	29.73	31.88	11.73	9.58	4.69	5.28	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	50.70	28.83	46.59	30.89	24.71	8.49	2.57	2.83	4.38	1.29
Adipocyte differentiation, day04, donor3	13025-139E1	43.49	27.88	37.08	23.42	20.35	4.18	3.62	3.90	3.07	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	64.66	32.33	57.02	24.69	34.68	7.64	3.53	6.47	4.11	2.94
Adipocyte differentiation, day08, donor1	13020-139D5	25.10	21.48	22.92	13.43	17.05	3.70	2.01	2.49	2.73	1.21
Adipocyte differentiation, day08, donor2	13023-139D8	39.70	23.88	47.44	24.21	31.63	6.46	4.84	1.61	3.23	2.58
Adipocyte differentiation, day08, donor3	13026-139E2	30.39	16.53	21.33	6.40	9.06	1.07	2.13	1.07	1.07	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	27.82	17.81	20.59	13.91	12.24	2.78	1.67	2.78	3.34	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	6.65	4.57	12.89	4.16	5.82	0.42	0.83	1.25	0.83	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	16.83	13.31	29.64	13.56	19.59	4.27	2.51	1.76	2.01	1.26
Adipocyte differentiation, day12, donor3	13027-139E3	13.74	9.82	12.76	5.89	8.84	1.31	1.31	0.65	1.64	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	7.31	6.09	12.79	7.00	7.00	0.91	0.91	2.44	2.13	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	17.46	15.03	3.98	2.21	1.10	1.99	0.44	1.77	1.10	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	3.94	2.87	1.79	0.00	0.00	0.36	1.08	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	8.39	10.78	1.20	1.20	0.00	1.20	1.20	1.20	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	0.18	0.36	0.18	0.00	0.00	0.00	0.00	0.36	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	0.41	1.03	0.21	0.41	0.21	0.21	0.21	0.62	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	77.24	87.88	43.94	22.77	20.14	7.32	4.35	1.95	4.00	1.37
Anulus Pulposus Cell, donor2	11463-119B5	29.88	45.06	26.21	6.86	4.65	2.20	5.39	1.47	1.22	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	65.60	35.94	13.93	7.19	4.04	7.64	4.49	2.70	2.70	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	63.82	45.15	21.27	8.25	8.68	6.51	11.72	3.04	1.74	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	66.35	32.10	19.26	21.40	10.70	0.00	8.56	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	65.76	48.72	18.83	10.76	6.88	6.88	8.37	2.39	0.90	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	77.14	58.17	15.18	3.79	6.32	6.32	3.79	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	77.23	33.00	17.16	6.60	7.26	4.62	7.92	2.64	3.30	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	51.98	38.66	13.65	7.15	6.50	4.22	6.17	0.65	3.57	2.27
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	60.19	50.49	16.50	9.22	6.31	4.85	9.22	2.91	1.94	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	62.36	36.23	14.85	10.10	7.72	4.16	5.94	2.38	1.19	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	67.42	53.86	16.57	9.04	4.90	6.40	7.53	1.13	2.26	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	77.65	47.89	21.04	13.79	5.81	7.98	9.43	2.18	2.90	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	52.66	32.60	11.28	5.02	2.51	3.76	6.27	2.51	7.52	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	41.35	47.44	29.32	10.87	10.71	3.62	4.28	1.32	2.14	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	57.32	38.21	21.84	6.82	8.19	4.09	6.82	1.36	1.36	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	67.40	29.86	29.10	9.35	11.31	7.09	5.58	2.26	4.22	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	62.15	46.08	18.75	9.11	8.04	9.11	6.43	1.61	1.61	2.14
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	54.98	41.38	14.74	10.01	5.67	4.72	9.64	3.97	1.89	2.08
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	56.93	34.21	23.25	9.89	7.22	5.88	4.54	1.60	3.21	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	57.55	39.99	25.36	10.73	3.90	7.80	8.78	4.88	4.88	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	49.59	39.47	16.42	6.47	5.14	4.15	10.12	2.82	3.81	1.82
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	62.44	31.22	25.22	8.41	4.80	2.40	1.20	2.40	6.00	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	35.40	24.78	21.24	3.54	14.16	7.08	0.00	0.00	10.62	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	49.57	45.11	21.78	11.32	6.35	5.66	11.49	1.72	2.40	1.03
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	41.95	58.73	16.78	4.19	4.19	4.19	12.58	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	80.10	44.17	19.42	10.19	10.68	9.71	7.77	4.37	5.34	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	54.26	39.46	23.91	8.73	7.21	6.07	6.83	1.90	3.79	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	66.63	37.55	21.80	6.06	6.06	4.85	3.63	0.00	7.27	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	58.71	40.47	18.81	6.84	4.56	3.99	17.10	0.57	1.71	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	50.02	40.19	23.52	7.48	8.34	6.20	9.62	2.99	2.99	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	70.20	28.65	25.29	8.00	9.55	5.42	7.74	1.29	4.13	2.06
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	52.08	36.60	16.42	8.91	5.63	5.16	8.45	1.41	3.28	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	44.05	45.34	23.47	10.61	7.07	3.22	8.04	1.61	1.93	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	49.94	33.53	17.12	6.42	6.42	6.42	9.27	0.00	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	47.38	33.34	15.21	7.60	4.09	3.51	6.43	1.17	1.75	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	45.46	39.74	21.98	7.23	6.62	5.42	9.03	2.11	2.41	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	62.96	28.51	16.63	10.69	10.69	11.88	9.50	0.00	2.38	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	69.16	46.79	15.26	5.09	9.66	8.14	4.58	3.05	4.07	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	63.42	47.63	22.41	9.68	5.86	7.13	11.72	2.04	1.53	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	57.18	23.51	16.52	8.26	8.90	4.45	5.08	0.64	3.81	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	52.22	38.84	15.10	7.34	3.02	3.45	7.34	0.43	2.16	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	48.48	38.95	17.99	9.10	5.93	5.08	11.85	1.48	2.54	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	62.93	28.42	18.27	5.22	4.06	5.80	4.64	1.16	3.48	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	66.13	43.46	18.89	9.45	5.67	8.50	9.45	1.89	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	41.87	37.97	17.63	6.27	4.92	4.24	9.15	1.86	2.88	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	55.59	48.64	20.85	4.63	6.95	6.95	0.00	0.00	6.95	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	67.60	27.46	25.35	10.56	6.34	2.11	8.45	0.00	6.34	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	49.74	41.81	21.01	9.65	2.57	5.15	9.86	3.65	3.65	1.50
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	81.22	35.50	23.46	9.02	6.02	8.42	11.43	0.60	3.01	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	61.96	52.49	10.21	7.29	7.29	5.83	5.83	1.46	0.00	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	54.48	37.93	17.47	7.36	4.83	4.83	7.59	1.61	2.76	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	63.76	40.80	22.95	5.10	7.65	2.55	5.10	5.10	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	66.86	33.56	36.36	11.95	7.88	5.59	4.07	1.27	3.81	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	55.33	50.37	24.98	9.29	8.67	2.68	9.29	1.45	3.30	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	73.44	32.44	26.32	9.79	6.73	8.87	5.20	3.06	3.98	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	77.44	58.32	26.29	12.43	7.65	9.08	7.17	1.91	0.96	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	58.98	40.13	24.17	11.31	5.32	3.99	10.87	2.44	1.77	1.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	62.56	33.57	24.41	9.15	12.21	7.63	6.10	0.00	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	76.99	40.99	15.51	7.75	2.22	5.54	11.08	0.55	2.77	1.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	53.49	38.92	21.98	7.94	4.77	5.56	10.06	2.38	2.12	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	70.87	35.25	33.44	9.81	7.27	9.45	9.45	2.91	2.18	1.45
Astrocyte - cerebellum, donor1	11500-119F6	14.12	34.27	19.16	5.16	2.33	1.23	2.58	0.74	1.84	0.61
Astrocyte - cerebellum, donor2	11580-120F5	14.21	19.17	9.76	4.45	0.68	1.37	3.94	1.88	0.51	0.51
Astrocyte - cerebellum, donor3	11661-122F5	10.49	11.33	5.45	3.99	2.94	1.47	1.26	0.63	0.42	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	8.71	11.15	1.39	5.23	1.05	1.39	1.05	1.05	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	6.15	7.93	3.88	2.43	0.65	1.13	1.13	0.16	1.29	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	3.73	4.47	1.19	1.04	0.89	0.45	0.15	0.45	0.30	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	5.16	8.95	0.69	0.11	0.11	0.80	0.80	1.72	0.46	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	6.01	7.27	0.50	0.25	0.00	1.00	1.38	3.13	1.25	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	4.55	7.28	0.57	0.11	0.46	0.80	0.80	2.73	0.68	0.23
Basophils, donor1	12241-129G9	0.26	0.00	0.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	1.08	1.08	1.80	0.36	0.72	0.36	0.00	1.08	0.00	0.00
Basophils, donor3	12243-129H2	0.44	3.82	0.29	0.59	0.15	0.15	0.15	0.15	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	3.45	3.88	0.43	0.00	0.00	0.65	0.22	0.86	0.43	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	1.37	3.20	0.46	0.00	0.00	0.00	0.46	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	0.00	0.00	0.00	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	3.77	3.77	0.63	0.00	0.00	0.00	0.00	1.26	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	2.08	2.91	0.83	0.42	0.00	0.21	0.21	0.83	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	2.30	11.05	1.38	1.15	0.46	1.15	1.38	0.23	0.23	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	4.50	6.12	1.26	0.72	0.36	0.54	1.08	0.90	0.00	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	0.32	0.00	0.32	0.00	0.00	0.32	0.00	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	0.00	0.00	10.34	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	3.38	4.51	1.13	0.56	1.13	0.00	1.13	1.13	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	2.04	4.64	3.90	0.00	1.48	0.93	0.74	0.37	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	1.76	1.10	1.10	0.00	0.22	0.44	0.00	0.88	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	25.19	25.19	194.17	22.64	41.61	3.11	1.70	4.81	2.26	3.68
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	10.99	8.72	82.64	7.20	13.65	1.52	0.76	4.93	0.76	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	23.67	17.42	163.38	16.11	30.90	4.27	1.31	4.93	1.97	1.31
CD14+ monocytes - mock treated, donor1	11863-125A9	7.37	7.08	27.75	2.75	7.81	0.87	0.87	3.04	1.01	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	9.96	8.75	43.15	3.02	10.56	1.51	1.51	2.11	1.81	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	2.37	2.37	15.40	0.47	4.74	0.24	0.00	1.18	0.00	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	3.52	5.02	20.92	1.00	4.52	0.33	0.84	1.51	0.00	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	5.80	3.31	36.71	3.86	9.94	0.55	1.10	0.55	0.00	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	1.24	1.98	9.17	0.74	3.97	0.25	0.00	0.00	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	2.35	2.35	10.77	0.78	3.13	0.78	0.39	0.39	0.39	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	3.74	2.31	28.67	2.67	8.01	0.53	0.53	0.53	0.18	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	0.65	0.87	7.40	0.44	1.74	0.22	0.22	0.00	0.00	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	8.66	10.54	38.40	3.98	11.94	1.87	2.81	1.40	0.47	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	8.98	13.73	77.62	5.81	18.48	1.58	0.53	1.06	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1.11	6.66	18.86	1.11	1.11	1.11	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	4.76	5.50	18.30	0.74	5.95	0.74	1.04	0.89	0.59	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	5.79	4.99	34.12	2.59	11.17	1.00	1.20	2.00	0.40	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	1.46	1.87	13.53	0.62	3.12	0.00	0.00	0.42	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	7.32	3.66	21.73	2.06	6.63	0.23	1.37	0.23	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	6.33	5.20	63.79	6.11	19.23	2.26	0.68	1.81	0.00	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	3.06	2.62	13.53	2.62	3.06	0.44	0.00	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	2.96	1.08	11.03	1.08	5.11	0.27	0.27	1.34	0.54	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	1.92	3.49	25.12	2.62	5.41	0.17	0.35	1.22	0.52	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	0.42	1.68	9.68	0.84	2.10	0.00	0.00	0.42	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	2.57	2.02	11.76	0.92	3.86	0.55	0.37	0.55	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	8.45	5.99	22.90	3.87	12.33	0.70	1.06	0.70	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	2.19	2.19	8.77	1.32	1.32	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	2.79	3.66	13.08	0.87	4.36	0.17	0.35	0.87	0.17	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	4.09	3.35	25.65	1.12	7.81	0.00	0.74	1.49	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	1.08	0.65	11.86	0.22	3.23	0.22	0.00	0.22	0.22	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	5.73	3.28	16.79	2.87	4.50	1.23	0.82	3.28	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	7.42	3.94	35.93	5.56	11.59	0.93	0.93	0.23	0.70	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	2.09	0.93	10.67	1.39	2.32	0.70	0.00	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	0.00	0.22	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	0.00	0.00	0.00	0.00	0.23	0.00	0.00	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	0.00	0.22	0.22	0.22	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	0.31	0.31	2.65	0.00	0.62	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	0.35	0.00	1.40	0.00	0.17	0.00	0.00	0.35	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	0.00	0.00	2.23	0.00	0.22	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	0.00	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.00	0.00	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	0.00	1.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	0.00	0.00	0.00	0.00	1.32	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	0.56	1.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	1.13	0.75	0.38	0.00	0.38	0.00	0.00	0.38	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	1.35	0.90	0.68	0.45	0.68	0.23	0.00	0.23	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	0.00	0.36	0.00	0.00	0.00	0.00	0.00	0.36	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	0.43	0.43	0.00	0.14	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	0.51	1.02	0.00	0.00	0.34	0.51	0.17	0.00	0.00	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	2.26	2.10	0.16	0.00	0.16	0.16	0.32	0.48	0.32	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	0.00	0.00	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	0.42	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	0.00	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	1.61	0.54	0.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	0.19	0.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	0.22	0.43	0.00	0.22	0.22	0.00	0.00	0.00	0.22	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	0.21	0.00	0.00	0.00	0.00	0.42	0.21	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	0.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	0.00	0.55	0.00	0.28	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	0.25	0.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	0.00	1.54	1.54	0.00	0.00	0.00	0.00	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	0.92	0.46	0.69	0.00	0.23	0.46	0.23	0.46	0.23	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	0.96	0.72	0.48	0.00	0.00	0.24	0.00	0.24	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	1.09	0.55	0.82	0.00	0.00	0.27	0.27	0.55	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	1.50	0.60	0.00	0.00	0.00	0.30	0.30	0.30	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	0.96	1.20	0.72	0.24	0.00	0.00	0.48	0.48	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	0.91	0.45	0.23	0.00	0.00	0.23	0.45	0.45	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	0.22	0.22	0.00	0.00	0.22	0.00	0.00	0.22	0.22	1.09
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	1.32	0.53	0.53	0.00	0.00	0.53	0.26	0.26	0.26	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	1.64	0.47	0.00	0.00	0.00	0.00	0.23	0.00	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	0.91	0.60	0.30	0.30	0.00	0.00	0.00	0.00	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	2.32	0.58	0.00	0.29	0.00	0.29	0.29	0.58	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	1.33	1.60	0.53	0.00	0.00	0.00	0.00	0.27	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	1.75	0.88	0.44	0.00	0.00	0.44	0.00	0.44	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	0.46	0.91	0.00	0.00	0.00	0.00	0.46	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	8.20	0.00	1.49	0.00	0.00	0.00	0.00	1.49	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	1.08	0.36	0.00	0.00	0.00	0.72	0.00	0.00	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	0.58	0.58	0.00	0.00	0.00	0.86	0.00	0.29	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	1.89	0.47	0.00	0.00	0.24	0.00	0.00	0.24	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	1.58	0.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	1.23	0.62	0.92	0.31	0.00	0.62	0.00	0.31	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	0.00	0.64	0.64	0.00	0.00	0.32	0.32	0.32	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	1.15	0.76	0.00	0.00	0.38	0.38	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	0.79	0.00	0.00	0.39	0.00	0.39	0.00	0.39	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	0.76	0.76	0.00	0.00	0.00	0.00	0.76	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	5.62	0.00	1.61	0.00	0.00	0.80	0.80	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	4.20	0.00	0.00	0.00	0.00	0.70	0.70	0.70	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	7.01	2.00	0.00	0.00	0.00	2.00	0.00	2.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	56.66	34.73	20.11	3.66	10.97	10.97	3.66	0.00	9.14	1.83
Cardiac Myocyte, donor2	11605-120I3	10.87	14.82	4.94	4.94	0.99	1.48	0.00	0.99	1.98	0.00
Cardiac Myocyte, donor3	11686-122I3	10.42	14.52	5.16	3.26	2.42	1.89	0.95	1.16	1.37	0.32
Chondrocyte - de diff, donor1	11261-116G1	20.11	15.25	8.32	6.59	2.08	1.73	3.47	1.73	0.35	1.04
Chondrocyte - de diff, donor2	11338-117F6	7.11	18.83	7.46	4.62	3.91	1.42	0.71	2.49	0.71	0.36
Chondrocyte - de diff, donor3	11410-118E6	6.37	12.17	3.30	3.41	2.39	1.02	0.34	1.02	0.68	0.23
Chondrocyte - re diff, donor2	11339-117F7	0.90	6.27	0.90	2.69	2.69	0.90	0.90	2.69	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	2.83	4.45	1.21	0.81	2.43	0.40	0.00	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	36.72	46.59	10.33	9.41	5.39	5.74	2.87	2.75	3.33	1.03
Ciliary Epithelial Cells, donor2	11323-117D9	27.15	30.57	5.77	4.28	3.21	2.57	4.49	2.35	1.71	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	23.36	28.23	6.73	5.75	4.25	2.83	3.45	1.95	2.30	0.80
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	30.63	33.01	26.13	8.34	10.45	3.39	3.30	2.48	2.20	0.73
Corneal Epithelial Cells, donor1	11526-119I5	5.05	3.73	0.00	0.44	0.44	0.66	0.44	0.88	0.22	0.22
Corneal Epithelial Cells, donor2	11606-120I4	0.00	3.41	0.00	0.00	1.14	0.00	0.00	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	2.30	2.81	0.00	0.26	0.51	0.00	0.00	0.26	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	5.12	5.78	172.03	9.25	33.18	0.99	0.50	2.48	0.66	1.32
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	2.84	7.25	145.72	12.30	34.70	0.95	0.63	2.52	0.00	2.52
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	3.45	89.72	0.00	27.61	0.00	0.00	6.90	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	3.24	5.29	98.81	8.96	35.42	0.43	0.11	1.62	0.11	1.30
Dendritic Cells - plasmacytoid, donor1	11228-116C4	120.94	80.97	27.67	5.12	5.81	17.08	7.17	6.83	7.86	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	94.01	65.94	28.73	1.31	3.26	5.22	5.22	4.57	7.83	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	77.43	81.79	22.26	1.45	0.97	3.87	14.52	3.39	1.94	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	17.84	28.35	51.03	6.67	12.01	1.83	0.83	1.00	2.00	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	15.84	12.32	37.55	4.69	4.69	0.00	1.17	2.93	1.76	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	52.32	24.32	53.73	8.77	11.03	3.68	0.28	1.41	4.52	2.26
Endothelial Cells - Aortic, donor3	11412-118E8	27.92	16.91	43.25	4.72	8.26	2.75	1.57	2.75	1.97	0.79
Endothelial Cells - Artery, donor1	11264-116G4	25.60	15.13	25.31	5.82	6.11	1.75	1.75	0.29	2.33	0.29
Endothelial Cells - Artery, donor2	11341-117F9	23.76	26.82	25.41	6.35	5.88	2.35	1.41	1.18	1.88	0.94
Endothelial Cells - Artery, donor3	11413-118E9	11.75	15.08	30.15	5.26	7.01	1.93	0.18	0.88	0.88	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	32.80	34.80	96.42	16.18	16.40	3.99	1.77	1.99	4.43	1.33
Endothelial Cells - Lymphatic, donor2	11317-117D3	40.16	31.95	73.94	10.95	14.00	5.78	3.04	4.56	5.17	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	27.34	29.04	87.11	12.97	14.10	3.10	3.38	0.85	3.38	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	6.54	12.78	18.42	1.78	2.97	0.30	1.78	1.49	0.89	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	5.73	6.77	5.73	0.52	1.56	0.52	0.00	1.04	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	1.70	3.54	5.96	0.99	2.41	0.43	0.00	0.57	0.28	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	36.41	50.42	110.83	6.00	4.80	2.40	12.40	3.60	1.60	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	7.86	15.20	13.63	4.72	3.67	1.57	2.10	1.05	1.57	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	52.68	57.77	98.15	16.52	22.36	6.21	2.73	3.23	5.47	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	58.44	31.50	48.67	6.74	11.73	8.26	3.69	4.56	3.26	1.30
Endothelial Cells - Umbilical vein, donor3	11400-118D5	50.56	26.38	49.10	7.94	12.95	7.57	3.42	5.01	5.37	1.71
Endothelial Cells - Vein, donor1	11267-116G7	7.96	13.65	30.71	2.28	11.38	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	10.48	15.37	47.50	2.79	7.68	0.70	0.00	2.79	1.40	0.70
Endothelial Cells - Vein, donor3	11416-118F3	31.24	21.35	52.60	6.28	11.15	3.45	3.30	2.36	2.04	0.79
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	1.47	2.93	0.00	0.24	0.24	0.00	0.24	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	11.49	9.44	2.87	0.82	1.64	1.23	2.46	2.05	1.64	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	53.65	9.42	34.38	7.01	9.31	4.60	4.05	1.86	3.28	1.42
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	10.94	2.82	3.58	1.30	1.52	1.30	0.43	0.43	0.76	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	33.59	41.24	28.26	19.16	16.13	4.97	2.55	1.82	2.30	1.33
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	70.01	75.33	139.34	42.44	38.76	8.73	7.64	2.32	6.55	2.18
Fibroblast - Aortic Adventitial, donor2	11326-117E3	35.96	42.82	25.52	11.29	11.60	4.22	5.80	2.21	2.53	1.27
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	97.75	117.25	182.07	51.91	22.40	6.32	17.92	7.11	3.95	2.90
Fibroblast - Aortic Adventitial, donor3	11401-118D6	48.50	46.51	28.90	23.92	15.28	7.64	6.98	2.99	3.65	1.66
Fibroblast - Cardiac, donor1	11268-116G8	15.88	8.62	5.90	3.18	2.27	1.36	2.27	1.36	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	7.58	6.82	7.58	5.31	4.55	1.52	1.52	1.52	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	14.98	18.61	10.09	5.20	5.36	1.42	1.42	0.63	1.26	0.95
Fibroblast - Cardiac, donor4	11452-119A3	34.86	29.40	26.98	13.94	12.12	4.24	1.82	1.82	3.03	0.91
Fibroblast - Cardiac, donor5	11456-119A7	26.27	37.56	28.68	8.50	3.81	3.30	9.39	3.05	1.65	1.40
Fibroblast - Cardiac, donor6	11460-119B2	20.47	27.74	18.19	7.12	5.61	2.12	4.40	1.82	1.36	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	15.68	30.55	3.35	2.55	1.07	1.47	2.01	1.47	0.80	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	18.98	19.85	2.16	3.45	0.00	1.73	1.29	1.73	2.16	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	39.55	35.16	1.46	2.93	4.39	2.93	1.46	2.93	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	57.20	47.28	6.46	3.92	2.77	5.77	3.00	4.15	3.00	1.61
Fibroblast - Conjunctival, donor3	11692-122I9	35.11	45.79	10.52	14.59	7.46	1.36	2.20	2.20	1.70	0.68
Fibroblast - Dermal, donor1	11269-116G9	48.83	35.92	27.47	11.97	8.69	3.99	6.10	1.64	3.29	1.17
Fibroblast - Dermal, donor2	11346-117G5	13.68	25.47	21.23	6.13	5.19	0.47	0.47	0.47	0.94	0.94
Fibroblast - Dermal, donor3	11418-118F5	37.84	37.96	28.89	11.61	11.12	3.63	4.84	2.30	1.81	0.60
Fibroblast - Dermal, donor4	11450-119A1	37.19	44.65	9.83	4.86	1.36	4.86	8.59	3.17	1.58	1.58
Fibroblast - Dermal, donor5	11454-119A5	51.11	37.51	10.12	4.88	1.74	4.19	7.85	2.27	2.44	1.57
Fibroblast - Dermal, donor6	11458-119A9	46.45	44.34	10.07	4.55	1.95	5.20	6.98	2.92	2.60	0.97
Fibroblast - Gingival, donor1	11237-116D4	59.35	55.81	24.78	19.16	18.32	7.70	4.58	1.04	5.00	1.67
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	50.04	33.54	38.25	19.13	17.03	3.93	6.55	3.14	3.14	1.31
Fibroblast - Gingival, donor2	11318-117D4	43.75	64.71	9.62	8.83	6.72	3.56	6.98	3.95	2.24	1.58
Fibroblast - Gingival, donor3	11394-118C8	39.06	32.68	12.28	11.99	10.64	6.19	2.32	2.22	1.74	1.93
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	48.83	54.02	13.51	10.39	3.12	3.12	3.12	9.35	0.00	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	37.53	37.88	5.29	6.70	6.17	4.93	4.58	3.17	3.88	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	41.62	33.36	20.27	10.76	8.89	1.56	5.77	2.49	2.34	1.87
Fibroblast - Gingival, donor6 (control)	11922-125H5	38.27	28.53	22.45	10.01	9.47	2.57	3.11	2.84	2.30	1.22
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	86.46	39.17	50.46	25.41	22.23	2.82	8.12	7.41	3.53	3.18
Fibroblast - Gingival, donor7 (control)	11924-125H7	63.47	31.15	31.88	18.87	11.85	6.43	7.90	3.51	5.70	2.78
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	54.95	39.95	26.32	14.04	11.86	4.91	6.68	3.68	4.77	2.18
Fibroblast - Gingival, donor8 (control)	11926-125H9	64.61	26.66	16.02	8.67	7.24	5.70	5.48	2.96	3.40	2.08
Fibroblast - Gingival, donor9 (control)	11927-125I1	87.46	41.67	16.73	10.71	8.66	6.31	7.63	5.28	6.02	3.52
Fibroblast - Lung, donor1	11270-116H1	12.23	28.55	10.87	6.80	9.52	1.36	2.72	2.72	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	65.65	62.67	26.86	19.40	14.92	10.45	4.48	2.98	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	40.73	45.58	14.56	9.07	11.61	4.22	4.22	2.95	2.32	1.27
Fibroblast - Lymphatic, donor1	11506-119G3	24.16	31.65	9.16	4.17	1.67	2.50	3.33	0.00	0.00	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	13.99	15.38	5.59	2.80	1.40	1.40	5.59	1.40	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	15.95	13.99	1.68	2.52	1.40	1.96	0.84	1.40	0.56	0.56
Fibroblast - Mammary, donor1	11540-120B1	49.53	38.57	13.40	6.90	4.06	1.62	1.22	4.06	3.65	1.22
Fibroblast - Mammary, donor2	11620-122A9	31.95	11.98	0.00	3.99	7.99	11.98	7.99	7.99	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	29.78	23.83	23.83	11.91	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	50.24	55.28	10.09	9.70	5.63	3.88	3.69	1.94	3.49	1.36
Fibroblast - Periodontal Ligament, donor2	11319-117D5	56.27	55.36	11.68	10.47	6.22	8.34	6.52	3.49	3.94	2.28
Fibroblast - Periodontal Ligament, donor3	11395-118C9	52.02	45.29	35.49	22.03	9.79	4.59	3.67	3.98	3.37	2.45
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	35.49	22.13	7.63	1.91	2.67	4.96	5.34	1.53	1.91	2.29
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	23.76	33.75	10.26	5.94	4.86	2.70	3.51	1.62	0.54	1.89
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	49.17	28.53	8.58	5.91	5.57	5.91	3.60	2.67	3.13	2.20
Fibroblast - Pulmonary Artery, donor1	11250-116E8	13.93	22.33	4.97	3.98	3.32	2.32	0.55	2.32	1.11	0.99
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	39.01	32.71	7.72	4.67	1.83	4.06	1.42	2.64	3.45	1.83
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	28.73	32.74	3.34	3.34	2.67	4.68	2.67	3.34	2.00	2.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	37.95	33.61	8.30	9.09	3.95	1.98	2.37	1.19	1.98	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	40.28	57.15	58.74	17.86	8.53	3.57	8.53	2.98	1.79	1.98
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	58.26	47.25	26.64	13.85	9.06	5.33	4.97	3.20	3.73	2.31
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	68.19	49.07	18.13	11.83	5.72	7.49	3.94	2.17	2.76	1.77
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	57.46	80.03	59.57	22.86	7.82	3.31	9.03	6.32	2.71	2.41
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	49.87	58.51	18.14	9.07	3.35	3.45	7.99	3.02	2.16	1.73
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	43.53	55.68	64.53	18.22	7.85	2.78	13.41	4.05	1.01	1.77
Fibroblast - skin normal, donor1	11553-120C5	57.43	48.73	30.03	13.95	11.32	3.45	2.95	3.61	2.95	1.15
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	118.90	140.76	126.52	90.43	63.16	16.04	12.23	6.82	7.82	3.41
Fibroblast - skin normal, donor2	11561-120D4	24.11	31.65	32.15	10.65	8.14	2.41	4.02	2.01	1.61	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	36.27	52.29	53.50	17.53	9.07	3.32	10.88	6.04	2.12	1.81
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	89.72	58.57	21.95	16.07	13.01	9.36	5.30	3.23	4.47	1.99
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	38.98	66.16	11.28	9.92	2.22	3.08	6.50	1.71	2.05	1.20
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	58.79	67.00	70.61	24.63	5.25	3.94	9.52	4.27	1.64	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	25.03	43.46	21.41	9.69	3.30	2.45	5.75	2.56	1.60	0.85
Fibroblast - skin walker warburg, donor1	11554-120C6	33.57	26.99	11.98	7.59	3.71	3.88	1.52	2.02	2.53	0.84
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	85.62	31.05	10.66	13.33	7.06	4.70	7.53	2.35	3.92	2.35
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	221.60	376.72	22.16	66.48	22.16	0.00	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	27.02	8.72	11.33	4.36	4.36	0.87	2.61	2.61	4.36	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	8.32	9.71	2.77	1.56	1.39	1.21	1.56	1.73	1.73	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	6.77	10.41	2.34	1.82	0.78	1.04	0.00	1.82	1.56	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	15.59	13.80	2.30	1.53	1.53	1.02	1.53	3.07	0.77	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	16.84	3.06	1.53	0.00	1.53	1.53	0.77	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	3.83	1.91	2.55	1.28	0.64	1.91	0.00	0.64	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	4.56	0.86	0.00	0.29	0.00	0.29	0.00	1.43	0.29	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	2.48	1.65	0.00	0.00	0.28	0.55	0.83	0.55	0.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	9.36	7.31	1.60	3.42	1.37	2.51	0.91	0.68	0.91	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	3.57	0.99	1.19	0.40	0.00	0.79	0.40	0.59	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	1.32	0.79	0.26	0.26	0.00	0.26	0.26	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	20.87	5.22	1.30	1.96	0.65	4.89	1.30	1.63	0.65	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	3.98	2.21	0.00	0.00	0.00	0.44	0.00	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	5.79	7.35	1.27	0.42	1.13	0.71	0.85	1.98	0.42	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	5.91	3.94	1.23	0.86	0.37	0.49	0.74	0.74	0.49	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	5.10	3.76	0.27	0.54	0.00	0.27	0.81	0.54	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	17.35	13.50	4.46	0.99	1.24	0.99	1.86	2.11	0.87	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	12.74	8.44	2.21	0.42	1.52	1.38	1.11	1.94	0.42	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	13.42	11.59	2.03	1.42	1.02	1.22	1.42	1.02	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	11.41	15.52	3.19	2.05	1.14	0.46	2.28	1.83	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	11.34	8.84	3.24	1.87	0.87	0.87	1.62	1.00	0.75	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	10.27	11.58	1.53	1.75	0.44	2.40	1.75	1.09	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	8.57	7.68	4.73	2.36	2.36	0.30	3.25	1.18	0.30	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	7.95	7.47	2.54	0.79	1.91	0.95	0.48	1.11	0.48	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	8.04	8.49	5.14	2.46	1.79	0.89	2.01	1.34	0.67	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	8.07	6.05	2.42	0.40	0.60	0.40	2.22	1.01	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	9.67	6.96	3.22	1.19	1.53	0.85	0.17	1.53	0.34	1.19
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	12.86	12.50	7.18	3.10	2.39	2.22	0.35	0.62	0.71	0.80
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	7.08	8.22	3.43	1.35	1.56	2.19	1.04	0.42	0.10	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	8.37	5.64	2.39	1.20	0.85	1.20	0.85	1.20	0.34	0.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	7.30	4.32	1.99	0.77	0.55	1.44	0.22	0.33	0.33	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	10.23	10.57	5.91	2.75	2.00	1.00	1.08	0.58	0.75	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	9.19	8.58	6.94	0.82	0.61	2.04	1.02	1.02	0.82	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	7.63	7.84	2.27	1.24	0.62	1.65	0.83	0.21	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	7.15	7.03	3.00	0.81	1.15	1.27	0.46	1.04	0.81	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	6.50	6.34	3.00	0.83	0.67	1.00	1.00	0.83	0.50	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	6.39	5.73	0.88	0.00	0.22	0.66	1.54	0.66	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	6.27	5.66	1.23	0.98	0.49	1.11	0.86	0.37	0.12	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	8.59	7.62	4.21	1.13	2.27	0.81	1.13	1.13	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	3.21	6.74	0.96	1.28	0.00	0.64	0.96	0.64	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	6.06	4.17	0.85	0.95	0.66	0.28	0.57	0.38	0.19	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	4.27	2.85	1.74	0.63	0.32	0.79	0.32	0.47	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	4.26	6.39	1.82	0.61	0.61	1.52	0.61	0.91	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	6.38	4.81	2.30	1.15	0.52	0.94	0.52	0.94	0.42	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	5.71	4.83	1.10	0.22	0.66	0.44	0.88	0.66	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	5.61	4.49	1.12	0.56	0.56	0.84	0.56	0.56	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	3.98	4.81	1.30	1.39	1.48	0.56	0.65	0.56	0.74	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	5.88	5.62	1.07	1.87	0.80	0.53	0.53	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	11.17	8.42	3.06	1.22	1.07	1.07	1.07	0.31	0.77	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	11.92	7.77	2.20	1.68	1.42	0.26	1.04	0.78	0.39	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	5.42	4.88	0.81	0.81	0.54	0.00	0.27	0.00	0.27	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	13.27	13.09	4.06	2.40	1.47	1.66	1.84	0.92	0.92	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	21.49	15.35	3.51	1.97	1.32	3.07	2.41	1.75	1.32	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	5.95	0.99	1.98	0.00	0.00	0.00	1.98	0.99	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	23.08	28.76	6.46	3.56	2.64	2.11	2.51	1.32	1.45	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	30.87	31.27	6.05	4.44	3.43	3.23	3.63	1.82	1.82	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	29.23	6.35	4.32	2.80	1.27	3.05	2.54	1.52	3.05	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	2.19	3.78	0.20	0.80	0.20	0.60	0.80	0.20	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	2.77	4.16	0.00	0.00	0.31	1.08	0.62	0.77	0.31	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	3.48	3.07	0.20	0.41	0.00	0.20	0.41	1.84	0.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	1.56	2.50	0.31	0.00	0.00	0.00	0.31	0.00	0.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	1.13	2.54	0.28	0.00	0.00	0.00	0.00	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	0.92	0.92	0.00	0.00	0.00	0.00	0.00	1.38	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	0.00	2.47	0.00	0.00	0.00	0.00	0.00	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	1.55	1.55	0.00	0.00	0.39	0.00	0.77	0.39	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	6.42	8.02	3.21	1.60	0.00	0.00	1.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	0.00	0.00	0.00	1.74	0.00	0.00	0.00	3.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	7.16	5.53	1.30	1.30	0.33	0.98	0.00	0.65	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	9.06	7.00	2.88	0.82	0.41	1.24	0.82	0.82	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	6.66	13.33	0.00	3.33	3.33	3.33	0.00	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	16.50	10.63	1.96	0.84	0.28	1.12	0.84	2.52	1.12	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	13.07	7.19	1.63	0.00	0.65	0.98	1.96	1.31	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	15.10	11.74	2.52	2.52	0.00	4.19	2.52	4.19	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	25.45	15.90	4.45	1.59	1.59	1.91	4.45	2.86	1.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	16.30	12.23	2.04	0.34	0.68	2.72	4.08	2.04	0.68	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	16.71	18.79	4.18	4.18	0.00	0.00	2.09	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	22.34	16.04	4.58	0.57	1.15	3.44	4.01	2.29	0.57	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	21.61	12.43	1.18	1.48	1.48	2.66	2.07	0.59	0.89	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	18.64	10.16	1.69	1.69	0.00	1.69	0.00	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	19.05	14.91	6.63	1.66	0.41	2.90	5.38	0.83	1.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	15.65	11.05	5.06	2.30	0.69	1.15	4.14	0.92	1.38	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	10.54	5.27	0.00	0.00	0.00	0.00	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	13.45	12.30	4.23	1.54	0.77	1.54	3.84	2.69	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	22.17	12.71	3.91	1.96	1.30	4.24	5.54	1.96	1.63	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	23.41	2.68	3.34	0.00	0.00	2.68	2.01	1.34	0.67	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	16.18	17.34	4.62	0.77	0.00	1.93	4.62	4.24	1.93	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	52.04	29.44	6.85	1.71	1.03	10.95	10.95	5.14	4.11	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	42.24	42.24	0.00	0.00	2.48	9.94	4.97	0.00	9.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	42.47	15.10	4.72	0.94	0.94	5.19	4.72	4.25	2.83	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	23.54	16.90	2.41	1.21	0.60	2.41	8.45	1.81	2.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	37.64	13.73	4.07	0.00	0.51	4.58	3.05	2.54	0.51	4.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	25.53	16.35	5.58	0.80	0.40	5.58	5.18	3.19	0.40	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	25.65	17.27	5.43	0.49	1.48	3.45	6.41	2.47	1.48	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	31.87	24.79	4.72	0.00	1.18	5.90	9.44	3.54	0.00	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	17.50	10.50	2.33	0.00	0.58	2.92	9.92	2.33	2.33	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	16.24	12.73	3.51	0.44	0.44	2.19	3.51	1.76	0.44	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	33.91	20.34	0.00	1.70	0.85	5.09	6.78	0.85	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	26.26	24.47	4.78	1.79	1.79	1.19	5.37	5.37	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	16.98	14.07	6.79	0.00	0.49	2.91	1.94	2.43	0.97	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	19.40	33.10	18.26	9.13	6.85	2.28	3.42	0.00	1.14	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	22.45	42.00	8.73	5.41	4.99	1.66	2.91	0.00	0.83	2.08
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	14.62	17.99	10.12	6.75	5.62	0.00	2.25	1.12	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	15.54	23.79	6.98	8.25	5.39	1.27	1.59	1.27	2.22	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	16.29	16.29	6.27	5.85	6.68	2.92	0.00	1.25	0.84	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	1.39	2.09	0.23	0.23	0.12	0.12	0.23	0.70	0.00	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	2.03	2.87	0.00	0.84	0.00	0.51	0.17	0.00	0.00	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	1.37	2.50	0.00	0.46	0.00	0.00	0.46	0.23	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	1.86	1.86	0.11	0.22	0.22	0.22	0.33	0.33	0.22	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	0.86	0.86	0.21	0.21	0.21	0.00	0.86	0.00	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	0.43	3.66	0.22	0.65	0.22	0.43	0.00	0.65	0.00	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	1.12	2.86	0.37	0.50	0.12	0.37	0.62	0.12	0.12	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	1.20	1.54	0.00	0.51	0.17	0.51	0.17	0.51	0.34	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	0.64	2.56	0.00	0.00	0.32	0.32	0.64	0.32	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	6.16	11.19	48.13	3.36	5.04	0.00	1.12	0.56	0.56	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	19.04	14.28	12.12	1.73	2.60	0.87	0.87	0.43	0.87	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	71.38	39.66	55.52	10.58	5.29	5.29	5.29	2.64	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	7.05	6.70	0.71	0.35	0.71	0.35	0.00	0.35	1.06	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	4.36	6.54	0.00	0.73	0.00	1.45	2.18	2.18	1.45	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	20.11	19.58	5.59	2.10	2.80	1.75	1.05	1.22	1.22	1.57
Hepatocyte, donor1	11523-119I2	2.42	12.11	6.05	2.42	1.21	1.21	0.00	3.63	0.00	0.00
Hepatocyte, donor2	11603-120I1	17.24	23.70	6.46	7.54	5.39	5.39	3.23	5.39	1.08	0.00
Hepatocyte, donor3	11684-122I1	31.29	12.88	31.29	10.43	9.20	2.45	6.14	3.68	1.84	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	10.31	15.56	1.57	1.05	0.35	1.05	0.35	2.97	0.52	1.22
Iris Pigment Epithelial Cells, donor1	11530-119I9	19.35	28.40	5.08	6.04	2.47	2.88	2.47	1.92	1.78	0.96
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	0.00	0.00	0.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	0.87	0.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	8.16	10.04	0.57	0.82	0.24	1.06	0.33	1.96	1.31	0.41
Keratinocyte - epidermal, donor2	11349-117G8	9.37	5.27	0.59	0.59	0.59	0.59	0.00	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	5.02	5.87	0.09	0.28	0.09	0.76	0.28	1.23	0.47	0.47
Keratinocyte - oral, donor1	11251-116E9	5.68	13.51	0.34	0.57	0.00	0.68	0.23	2.61	0.11	0.11
Keratocytes, donor1	11527-119I6	44.35	37.13	2.75	4.81	3.09	3.44	4.13	2.41	1.72	2.41
Keratocytes, donor2	11607-120I5	29.30	21.09	5.86	4.69	5.86	2.34	2.34	1.17	1.17	0.00
Keratocytes, donor3	11688-122I5	33.99	22.53	10.28	10.67	8.69	1.98	4.15	2.17	1.58	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	11.87	24.81	2.16	5.39	1.08	2.16	1.08	2.16	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	10.50	22.61	2.42	2.08	1.38	1.73	1.38	1.85	1.15	0.23
Lens Epithelial Cells, donor3	11690-122I7	22.70	21.29	8.98	5.25	4.44	2.02	1.51	1.21	3.33	0.91
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	12.57	10.20	20.28	5.69	4.15	1.19	0.71	1.30	0.59	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	9.77	13.67	25.40	3.63	5.86	1.67	3.35	1.12	2.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	15.74	22.35	28.96	5.67	8.03	2.68	3.78	1.26	1.57	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	8.07	9.14	10.75	3.23	0.54	0.00	1.08	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	14.18	11.98	27.10	6.30	5.67	1.26	1.26	0.95	0.63	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	13.05	11.10	14.12	2.37	3.67	1.19	2.26	1.40	0.43	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	6.98	11.08	14.77	1.23	3.69	0.82	1.23	0.82	1.23	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	6.57	13.91	18.20	3.54	3.79	0.76	0.51	0.25	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	10.13	14.64	23.36	2.82	5.63	1.13	3.10	0.99	1.97	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	8.70	9.89	14.24	3.16	1.98	0.40	1.58	0.79	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	8.34	12.41	30.25	5.23	5.04	0.97	1.74	0.58	0.78	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	6.11	11.11	11.11	1.67	2.04	0.56	0.93	0.00	1.11	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	9.76	14.63	14.98	4.53	3.48	0.00	0.35	0.35	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	12.88	12.64	24.33	4.05	4.53	1.19	1.19	0.72	1.43	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.61	13.60	17.03	3.30	3.98	1.24	0.55	0.69	0.82	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	8.31	9.85	11.09	2.46	4.62	0.92	1.23	0.31	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	9.04	9.35	19.64	2.18	3.43	0.31	1.56	0.62	0.62	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	12.81	12.26	17.38	4.76	5.31	0.91	2.01	0.91	1.83	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	7.24	10.53	12.18	2.30	4.61	0.99	0.00	0.99	1.32	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	9.08	13.18	17.28	2.34	4.39	0.29	1.17	0.88	0.88	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	11.70	9.21	12.70	1.99	4.73	0.75	0.75	1.00	1.24	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	11.15	9.70	12.12	1.45	4.85	0.97	0.97	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	15.62	12.39	28.28	2.69	6.19	2.15	1.62	0.54	1.08	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	14.23	16.35	20.89	2.72	4.69	1.51	2.57	1.36	1.36	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	13.48	7.78	7.78	4.67	1.04	2.07	0.00	1.56	1.04	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	14.24	14.66	28.69	5.86	9.21	1.47	0.84	1.47	0.84	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	15.04	16.54	15.94	2.26	4.81	1.20	2.41	0.30	1.20	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	6.19	8.25	13.07	2.06	0.69	0.69	2.75	0.69	1.38	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	9.03	12.42	28.97	5.08	6.02	0.56	1.13	0.75	0.56	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	9.12	12.19	14.95	3.18	4.03	0.64	0.85	0.85	0.95	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	12.11	10.18	13.08	1.45	1.45	0.97	0.97	0.48	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	5.62	12.24	20.51	5.62	6.28	0.33	2.32	0.99	1.32	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	14.25	15.11	19.95	3.59	4.96	1.61	2.11	1.24	1.12	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	14.07	14.81	18.51	4.44	2.96	1.11	2.22	3.33	2.22	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	7.41	12.60	23.47	5.68	6.42	0.74	2.72	0.49	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	9.90	10.31	14.44	1.92	3.99	1.10	2.34	0.41	0.27	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	9.97	11.26	16.08	3.86	4.50	1.29	0.96	1.29	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	19.48	15.22	31.65	5.48	9.13	1.52	1.52	1.22	2.43	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	16.38	22.67	21.69	2.24	6.02	2.24	2.38	1.12	1.68	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	12.09	14.93	12.44	2.84	4.62	1.07	0.71	0.00	0.71	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	9.21	7.76	21.81	1.94	6.30	0.00	0.00	0.48	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	11.51	11.83	20.07	3.27	4.36	0.78	2.02	0.62	1.24	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	6.45	11.46	16.47	5.37	5.01	0.72	1.07	0.36	1.43	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	11.76	11.76	30.38	5.55	6.21	0.98	0.33	0.65	0.65	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	15.54	11.06	16.95	4.47	3.77	1.88	3.53	0.94	1.18	0.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	13.24	14.85	24.13	5.32	5.20	1.86	1.24	0.99	1.73	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.43	7.17	18.95	5.89	5.63	1.54	1.54	0.51	0.51	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	14.02	12.83	21.18	4.48	4.18	1.49	2.98	1.19	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	4.53	2.27	2.27	0.00	0.00	4.53	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	12.27	13.81	4.60	0.00	0.00	1.53	2.30	3.07	0.00	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	13.36	8.91	1.48	1.48	0.00	0.74	2.23	1.48	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	16.50	20.31	3.39	1.27	0.85	1.27	0.85	2.96	1.27	1.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	18.99	9.85	2.11	0.00	1.41	1.41	1.41	1.41	0.70	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.94	5.60	2.80	2.80	2.80	1.87	0.00	2.80	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	20.10	20.10	1.55	1.03	0.00	2.06	1.03	0.52	0.52	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	5.95	13.08	7.14	0.00	1.19	3.57	0.00	2.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	10.18	16.29	4.98	3.39	1.13	1.13	0.23	2.49	0.90	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	22.39	20.94	4.07	2.33	2.33	2.91	1.74	1.45	1.16	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	17.11	19.81	3.60	1.35	1.80	1.80	2.25	1.35	2.25	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	17.07	19.37	6.10	2.85	2.44	2.71	0.81	2.44	1.76	1.22
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	25.16	13.35	2.57	1.54	2.05	4.11	1.54	2.05	1.54	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	15.17	19.41	3.88	1.41	0.35	2.47	1.76	2.82	0.71	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	14.66	11.99	4.66	1.33	0.00	0.67	2.00	1.33	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	19.87	20.38	2.55	4.08	1.53	4.08	4.08	5.09	2.55	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	16.28	20.54	1.87	1.87	1.33	2.40	1.07	2.93	1.07	1.87
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	16.44	20.97	2.27	3.21	1.51	2.08	3.78	3.40	2.08	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	22.70	23.93	3.07	2.45	3.68	3.07	4.29	2.45	1.23	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	20.39	15.49	7.34	3.26	0.82	3.26	2.45	4.89	1.63	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	15.83	23.32	3.12	1.04	1.67	4.16	3.96	0.83	1.46	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	32.51	27.19	4.76	1.68	0.84	5.32	3.64	1.68	1.40	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	19.58	19.58	6.18	1.03	1.03	0.00	2.06	2.06	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	18.00	25.84	2.03	3.19	0.87	2.32	3.48	1.16	1.16	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	17.94	20.63	4.48	2.39	1.49	4.19	3.59	1.79	0.60	2.09
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	17.15	23.24	2.77	1.66	1.11	0.55	1.66	1.66	0.55	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	15.20	21.56	4.95	2.47	1.06	3.89	3.18	3.18	0.35	2.47
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	24.34	18.07	4.79	1.48	1.84	4.43	3.32	4.43	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	12.66	14.97	3.45	2.30	0.00	3.45	1.15	4.61	2.30	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	11.13	14.97	3.07	2.69	3.07	2.30	3.07	2.69	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	20.38	15.85	3.40	3.96	0.57	1.70	3.40	2.26	1.13	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	14.77	18.05	8.20	3.28	0.00	0.00	2.46	1.64	1.64	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	13.56	20.79	1.81	1.36	0.00	2.71	1.81	2.26	0.90	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	13.64	22.98	3.59	2.15	2.87	3.59	5.03	1.44	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	23.90	19.42	2.24	0.75	1.49	2.24	2.99	2.99	1.49	2.99
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	15.61	23.78	1.86	2.97	1.49	1.11	2.97	2.23	1.49	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	24.12	21.54	4.31	1.29	3.45	3.45	3.88	1.29	1.29	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	17.13	11.99	1.71	1.71	0.86	0.86	0.86	1.71	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	18.32	19.99	4.33	2.00	0.67	2.00	4.66	3.00	1.67	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	28.96	25.94	1.81	0.60	3.02	4.83	3.62	3.62	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	18.49	12.80	2.13	0.00	1.42	1.42	5.69	2.84	1.42	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	14.78	17.87	5.50	1.37	1.03	3.44	3.09	3.44	1.72	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	22.54	20.40	1.07	1.61	0.00	2.68	1.61	1.61	1.07	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	10.77	12.12	1.35	0.67	0.67	2.02	1.35	4.04	1.35	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	17.04	24.08	4.07	1.11	2.59	3.33	4.44	1.48	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	6.98	18.61	3.49	0.00	2.33	0.00	0.00	3.49	0.00	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	12.69	15.87	0.00	0.00	0.00	2.12	5.29	2.12	1.06	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	16.01	21.61	2.40	3.60	0.80	2.00	0.80	2.80	1.60	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	19.63	13.08	0.73	2.91	0.00	0.73	3.63	1.45	0.73	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	19.16	22.23	3.07	3.07	0.77	0.00	0.77	3.07	0.77	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	14.80	15.78	2.47	1.97	0.00	3.95	2.96	2.96	0.99	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	20.70	16.00	3.76	0.94	1.88	1.88	2.82	1.88	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	15.08	16.09	3.02	2.51	1.01	3.52	2.01	4.53	1.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	12.62	20.28	4.51	3.15	2.25	3.60	3.15	3.60	2.25	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	13.77	6.88	0.00	1.72	5.16	1.72	6.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	19.15	18.70	5.79	2.67	3.12	1.78	2.67	1.78	1.34	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	17.21	21.12	3.91	1.17	1.96	2.35	3.13	1.96	1.96	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	13.19	12.53	1.98	0.66	0.00	1.98	4.62	1.98	0.66	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	10.90	20.24	5.71	2.08	1.56	1.56	2.08	2.08	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	15.31	24.94	2.63	2.63	0.88	1.31	2.19	2.19	0.88	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	21.80	16.21	3.91	0.00	2.80	2.24	2.24	5.03	1.12	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	14.57	18.55	2.65	2.65	0.44	0.44	2.65	3.97	2.65	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	17.74	16.59	2.31	2.31	1.54	1.93	3.86	4.63	1.54	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	20.76	16.20	2.03	2.53	1.52	5.06	2.53	0.51	2.53	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	18.74	22.11	2.40	0.00	0.96	2.40	2.40	1.92	0.96	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	14.31	17.49	3.18	3.18	1.59	3.58	2.39	1.99	0.40	2.78
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	21.27	25.52	4.86	1.22	2.43	2.43	2.43	2.43	0.61	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	11.07	10.38	7.61	1.38	1.38	1.38	4.15	3.46	1.38	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	17.10	19.38	2.66	3.80	0.38	4.56	3.04	1.14	1.52	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	26.85	28.40	4.65	2.58	1.55	4.65	3.10	3.10	1.03	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	13.91	11.49	0.60	0.60	0.60	1.21	3.63	1.81	0.60	3.02
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	17.75	26.62	4.75	3.49	1.90	1.27	2.54	1.90	1.27	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	23.46	15.46	4.80	1.60	2.13	7.46	3.20	1.07	1.60	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	15.52	12.07	5.75	0.57	0.57	2.87	1.72	2.30	1.15	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	22.63	20.06	4.63	1.54	1.54	2.57	2.57	4.11	1.54	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	30.42	20.51	3.54	1.41	0.71	1.41	3.54	2.83	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	16.46	15.32	6.24	0.57	0.57	3.97	1.70	0.57	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	19.14	26.21	0.83	2.50	0.83	3.74	3.74	2.08	1.66	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	18.01	31.32	4.70	3.13	2.35	3.13	3.92	1.57	0.00	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	12.11	21.71	3.76	1.67	0.00	2.09	2.51	2.51	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	12.55	14.40	3.25	2.32	1.86	0.93	3.25	2.32	1.39	2.32
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	14.72	18.06	4.01	2.68	2.68	6.69	3.35	2.68	1.34	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	11.76	21.92	8.02	2.14	0.00	3.21	3.21	2.67	1.07	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	13.34	18.99	3.64	2.83	1.21	2.42	2.02	1.62	0.40	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	22.94	21.11	0.00	1.84	0.00	1.84	2.75	1.84	0.92	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	24.01	15.11	8.00	4.45	0.89	4.45	2.67	0.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	27.92	13.68	5.13	0.00	0.00	2.85	1.71	4.56	1.71	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	23.77	16.10	4.60	3.83	1.53	3.07	4.60	0.77	1.53	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	34.47	16.96	4.92	0.55	0.55	1.64	3.28	0.55	1.64	3.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	16.48	20.05	4.90	4.01	1.34	0.89	2.23	4.01	0.45	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	21.06	12.74	6.50	3.64	1.30	1.30	1.04	1.04	1.30	1.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	14.59	9.28	3.32	1.33	0.00	1.33	0.66	2.65	1.99	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	43.65	14.55	2.08	2.08	4.16	4.16	8.31	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	26.44	24.84	177.77	27.12	58.35	3.65	1.60	2.73	0.23	1.14
Macrophage - monocyte derived, donor2	11313-117C8	19.27	22.39	101.48	20.00	29.18	2.39	0.73	2.75	0.92	1.84
Macrophage - monocyte derived, donor3	11389-118C3	23.46	15.60	93.20	15.47	35.00	3.41	1.97	3.28	0.66	2.49
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	1.59	2.66	1.59	0.00	1.59	0.00	0.00	1.06	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	7.45	9.19	1.43	2.06	0.63	1.11	0.32	3.49	0.48	0.16
Mallassez-derived cells, donor3	11930-125I4	5.70	7.92	0.28	1.11	0.28	0.42	0.00	1.25	0.69	0.42
Mammary Epithelial Cell, donor1	11273-116H4	39.96	42.75	7.47	5.18	4.58	5.98	5.58	1.79	3.79	1.49
Mammary Epithelial Cell, donor2	11350-117G9	45.46	44.01	11.87	6.08	4.05	5.79	6.37	1.45	3.76	1.74
Mammary Epithelial Cell, donor3	11422-118F9	9.48	12.22	2.49	0.75	0.50	0.50	1.50	1.25	1.00	0.50
Mast cell - stimulated, donor1	11487-119E2	43.39	10.85	12.88	1.36	3.39	4.75	4.75	3.39	0.68	6.78
Mast cell, donor1	11563-120D6	56.77	55.69	2.38	1.62	1.08	7.14	6.06	10.06	7.14	11.90
Mast cell, donor2	11565-120D8	2.38	3.27	2.67	0.30	1.19	0.59	0.59	1.19	0.30	1.19
Mast cell, donor3	11566-120D9	5.63	9.68	1.80	0.45	1.35	1.13	0.68	3.83	0.45	0.45
Mast cell, donor4	11567-120E1	7.45	7.62	1.42	0.18	0.71	0.71	1.42	5.85	1.06	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	49.24	26.39	1.77	1.89	0.22	4.66	7.21	7.54	4.66	7.87
Mast cell, expanded and stimulated, donor8	11942-126A7	35.02	7.59	1.75	0.58	0.00	1.17	1.17	2.92	1.17	5.25
Mast cell, expanded, donor5	11939-126A4	68.37	43.94	1.84	2.98	1.38	4.82	5.97	10.32	4.70	6.08
Mast cell, expanded, donor8	11941-126A6	25.27	14.90	0.50	1.17	0.50	3.01	4.35	5.52	3.68	5.86
Melanocyte - dark, donor1	11502-119F8	2.19	3.48	2.19	0.60	1.39	0.10	0.40	0.40	0.80	0.30
Melanocyte - dark, donor2	11582-120F7	7.96	14.88	3.46	0.69	2.08	1.73	0.69	2.08	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	0.80	1.45	0.07	0.07	0.14	0.14	0.07	0.14	0.22	0.00
Melanocyte - light, donor1	11274-116H5	0.00	0.47	0.24	0.00	0.00	0.00	0.00	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	3.47	5.20	0.87	0.00	1.73	0.00	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	3.64	3.02	0.52	0.21	0.00	0.31	0.10	0.10	0.10	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	21.96	36.23	7.32	3.10	0.74	2.61	2.85	1.98	3.10	0.62
Meningeal Cells, donor2	11573-120E7	14.52	29.49	4.84	3.52	0.00	2.64	3.52	3.52	1.76	0.88
Meningeal Cells, donor3	11654-122E7	36.19	45.48	7.58	7.09	5.22	3.42	1.71	2.12	3.10	1.79
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	72.43	85.83	25.38	12.55	13.40	8.55	4.56	1.71	3.99	3.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	25.36	36.53	10.57	4.13	2.92	3.82	1.61	1.51	2.72	0.70
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	2.63	2.63	3.94	2.63	1.31	1.31	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	20.93	10.47	3.92	2.62	1.31	3.92	2.62	1.31	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	32.29	36.60	19.38	7.18	6.46	6.46	0.72	2.87	3.59	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	55.48	34.31	10.80	5.93	3.39	4.66	2.75	1.48	2.96	2.75
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	33.17	31.16	7.54	5.53	2.51	3.02	3.52	2.01	3.02	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	32.52	30.33	10.11	6.81	4.40	5.71	1.76	1.10	3.08	1.10
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	47.49	30.68	6.58	8.77	3.65	8.77	2.19	0.73	5.84	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	31.51	34.37	9.62	5.93	4.30	4.50	2.05	1.64	1.23	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	27.01	57.90	28.81	8.86	3.19	2.35	3.74	1.52	1.11	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	8.18	7.43	2.97	1.49	1.12	1.12	0.00	0.37	0.74	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	13.29	19.47	3.29	2.50	1.71	1.45	0.53	0.92	1.05	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	23.44	13.35	3.26	2.97	1.48	2.67	0.89	0.30	1.48	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	21.02	4.67	0.00	0.00	0.00	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	17.29	12.81	1.28	1.28	1.92	3.84	1.92	0.64	1.28	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	35.44	69.47	16.30	9.92	10.63	4.61	1.06	1.77	3.90	1.42
Mesenchymal stem cells - hepatic, donor0	11218-116B3	5.94	18.14	4.38	1.25	1.88	1.56	1.56	1.56	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	13.79	29.75	3.63	3.63	1.45	2.18	1.45	1.45	2.90	0.73
Mesothelial Cells, donor1	11247-116E5	19.89	24.93	1.86	2.12	2.39	2.65	1.06	1.59	1.33	1.06
Mesothelial Cells, donor2	12156-128G5	9.01	13.51	1.50	0.50	0.00	1.00	1.00	1.00	1.00	2.50
Mesothelial Cells, donor3	11402-118D7	2.96	4.99	0.36	0.29	0.00	0.29	0.14	0.51	0.14	0.43
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	128.28	36.46	66.17	12.15	29.71	17.55	10.80	6.75	8.10	16.20
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	25.61	25.61	82.99	16.01	24.38	1.23	5.66	2.71	0.25	2.46
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	25.62	16.20	71.26	15.02	24.73	2.65	2.06	2.36	0.88	2.36
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	3.46	55.31	13.83	0.00	3.46	0.00	3.46	0.00	6.91
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	12.71	13.33	61.99	8.99	13.95	1.55	3.10	1.86	0.62	2.17
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	14.73	17.22	57.04	15.35	20.95	1.45	1.04	1.24	2.07	1.45
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	62.53	16.21	34.74	4.63	13.90	6.95	6.95	2.32	4.63	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	22.77	20.27	70.07	14.26	21.27	1.00	3.50	3.00	1.25	3.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	29.79	13.03	59.58	18.15	20.95	3.26	3.72	1.40	0.93	4.65
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	136.26	38.93	19.47	19.47	0.00	0.00	38.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	19.10	15.65	54.06	12.19	14.43	2.44	3.25	2.03	1.22	3.05
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	17.42	22.17	57.41	9.90	18.21	0.79	3.17	1.98	1.58	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	76.96	17.10	17.10	0.00	0.00	8.55	8.55	0.00	8.55	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	22.12	10.62	52.21	7.96	7.96	1.77	1.77	3.54	0.00	3.54
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	12.16	20.52	56.23	9.88	19.76	1.52	1.14	2.28	0.76	2.66
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	21.05	5.26	23.69	6.58	19.74	3.95	3.95	2.63	0.00	3.95
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	15.49	20.16	56.45	7.64	14.43	1.91	2.97	2.12	1.06	0.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	13.81	6.45	37.75	6.45	3.68	0.92	1.84	0.92	0.00	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	18.48	14.90	43.52	5.37	14.31	3.58	2.98	2.38	1.19	2.98
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	26.83	6.71	8.38	1.68	6.71	3.35	5.03	5.03	1.68	6.71
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	135.80	33.95	0.00	0.00	33.95	33.95	0.00	33.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	19.57	17.56	44.16	6.52	14.30	0.75	4.27	0.75	0.50	1.51
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	16.16	10.22	38.03	10.46	12.60	1.43	1.90	1.66	0.71	2.14
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	16.59	8.29	20.46	2.76	8.85	2.76	0.55	2.21	0.55	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	10.82	9.67	37.99	5.07	9.67	1.61	0.92	1.84	0.69	1.15
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	12.62	12.20	42.91	13.04	16.20	0.84	1.05	1.26	0.21	1.26
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	12.64	9.17	34.04	5.10	12.23	1.22	1.83	1.22	0.00	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	13.30	12.23	36.90	8.80	14.37	1.72	1.07	1.72	0.64	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	12.67	12.23	34.23	8.22	11.56	1.33	1.11	0.89	0.44	1.33
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	0.00	30.96	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	9.64	9.20	32.63	5.26	7.88	1.75	0.88	0.22	0.22	1.31
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	17.24	4.56	19.26	3.04	12.67	1.52	1.01	2.53	1.01	3.55
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	13.26	4.97	19.88	1.66	4.97	3.31	4.97	1.66	0.00	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	16.04	8.97	30.44	5.71	10.60	1.63	1.09	1.63	0.27	1.90
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	13.23	8.82	35.58	5.88	12.35	1.76	1.76	0.88	0.88	2.35
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	23.99	7.63	13.08	1.09	6.54	2.18	3.27	1.09	1.09	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	10.57	9.13	24.03	5.29	7.69	0.48	0.48	0.96	0.00	2.40
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	7.20	12.01	35.62	9.61	10.41	0.40	0.40	0.00	0.00	1.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	20.57	12.34	8.23	2.74	2.74	10.97	2.74	0.00	1.37	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	5.01	6.51	22.53	3.00	7.01	0.50	0.50	1.00	0.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	26.95	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	14.27	6.12	4.08	0.00	4.08	4.08	0.00	0.00	0.00	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	6.57	5.69	21.02	7.44	6.13	1.31	0.88	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	14.35	8.83	14.35	4.41	2.21	3.31	3.31	3.31	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	6.40	1.92	4.48	1.28	6.40	1.28	1.28	0.00	0.00	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	7.19	5.70	18.35	5.95	6.45	1.74	0.50	0.99	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	8.35	3.48	11.83	2.78	4.87	2.09	0.70	1.39	0.70	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	24.31	2.21	0.00	6.63	4.42	2.21	2.21	0.00	0.00	4.42
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	4.79	6.50	14.36	3.42	6.15	1.37	1.03	1.37	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	8.75	4.81	21.01	5.25	3.50	0.88	0.00	0.88	1.31	1.75
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	16.33	4.26	3.91	1.78	2.49	3.20	0.71	1.42	0.71	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	4.21	8.42	11.22	4.77	4.21	0.00	0.28	1.12	0.00	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	3.74	4.16	17.46	4.16	5.40	1.25	0.83	1.25	0.00	2.49
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	9.32	2.33	4.66	2.33	1.75	1.75	0.58	1.75	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	3.62	8.45	9.05	5.13	3.02	1.81	0.60	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	5.01	8.77	19.20	7.10	3.76	0.42	0.42	0.83	0.42	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	7.22	0.00	0.00	7.22	0.00	7.22	7.22	0.00	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	3.69	1.85	4.62	2.77	5.54	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	9.11	3.98	25.61	5.69	5.12	2.28	0.57	0.00	0.57	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	4.97	2.49	4.70	3.45	4.01	0.69	0.41	1.11	0.83	0.83
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	1.04	3.63	8.03	2.85	3.37	0.52	0.26	0.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	6.43	3.86	14.16	6.43	4.29	0.00	2.14	2.57	0.43	2.14
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.81	0.64	3.18	4.45	3.18	0.00	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	2.40	2.14	6.94	3.47	3.74	0.27	0.00	0.53	0.53	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	11.67	11.08	53.28	14.07	17.96	2.39	0.90	1.80	0.00	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	5.23	2.97	8.05	3.11	2.97	0.71	0.42	0.85	0.14	0.71
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	1.59	3.19	10.51	3.82	3.50	0.32	0.00	0.64	0.00	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	5.75	4.64	19.46	4.42	6.63	0.44	0.44	1.33	0.88	1.99
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	4.17	3.79	7.96	3.41	2.65	0.00	0.00	0.76	0.38	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	3.41	4.26	7.39	5.40	2.56	1.42	1.42	0.57	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	7.37	4.92	29.25	8.85	7.87	0.49	1.72	1.23	0.74	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	15.64	3.91	9.12	3.91	5.87	1.30	0.65	1.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	3.23	6.17	13.23	6.17	5.88	0.00	0.29	0.29	0.00	1.18
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	10.09	5.19	43.83	10.96	12.69	1.15	0.86	2.31	1.15	1.44
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	16.49	7.42	46.57	11.54	14.84	2.89	2.47	3.30	0.82	2.89
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	3.57	4.17	17.57	6.25	8.34	0.30	0.00	0.89	0.00	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	7.53	48.97	0.00	30.14	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	7.13	28.52	8.91	5.35	1.78	0.00	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	18.73	11.50	63.41	5.91	12.16	4.93	1.64	4.60	0.99	1.64
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	19.99	11.57	46.29	4.21	8.42	1.05	1.05	1.05	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	13.84	10.28	68.79	7.91	14.04	1.78	1.38	2.97	1.38	2.37
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	11.18	12.11	66.12	4.66	15.83	0.93	2.79	2.79	1.86	2.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	12.77	15.40	91.63	6.38	23.28	1.13	0.75	4.51	0.00	1.88
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	8.79	6.92	35.16	5.06	10.92	0.80	1.33	0.80	0.27	2.93
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	13.91	10.52	50.56	8.93	13.80	1.81	0.23	2.26	1.47	1.36
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	11.79	4.42	41.99	2.95	8.10	0.00	0.74	2.21	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	15.39	8.79	68.15	5.13	13.19	1.47	0.37	1.83	1.10	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	31.11	21.78	35.78	10.89	12.44	0.00	1.56	0.00	1.56	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	12.29	7.48	25.12	3.74	6.41	1.60	1.07	2.14	0.53	3.21
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	3.86	7.73	0.00	3.86	0.00	0.00	3.86	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	13.13	4.04	42.42	6.06	8.08	2.02	0.00	3.03	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	15.18	9.28	37.53	3.79	9.28	2.11	2.11	1.26	1.26	1.69
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	4.09	13.62	5.45	6.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.91	0.64	8.90	1.91	1.27	0.64	0.00	1.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	5.67	1.62	2.43	0.00	3.24	0.81	0.00	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	6.04	13.59	3.02	3.02	3.02	0.00	4.53	1.51	7.55
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	5.71	5.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	6.52	6.52	13.05	0.00	0.00	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	4.75	19.01	0.00	0.00	0.00	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	25.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	7.54	10.34	2.59	4.09	1.72	0.86	0.65	1.29	0.65	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	13.07	12.02	1.05	3.14	0.52	2.09	2.09	2.09	1.57	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	186.90	8.68	91.45	16.02	14.02	15.35	12.68	6.01	10.68	4.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	135.23	7.51	37.56	6.68	14.61	8.35	9.60	1.67	7.51	7.10
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	423.06	45.82	47.16	37.08	48.68	21.49	20.73	3.80	23.20	8.37
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	298.42	28.73	38.30	11.17	14.36	33.51	44.68	7.98	17.55	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	144.83	4.08	74.11	10.88	20.40	8.16	7.48	2.04	8.84	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	354.66	244.41	22.05	33.08	25.73	20.21	58.80	3.68	11.03	5.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	186.25	5.02	58.59	11.72	15.90	12.56	9.21	4.60	9.63	2.09
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	190.83	12.09	66.94	18.60	20.22	15.34	18.60	3.95	7.44	3.95
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	202.40	8.65	49.72	14.86	19.19	14.32	12.16	3.78	8.11	5.67
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	104.07	30.69	40.79	14.93	14.93	11.56	14.93	5.89	8.83	3.57
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	267.23	1414.11	55.67	55.67	11.13	22.27	44.54	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	103.24	10.42	125.58	18.37	29.78	10.92	5.46	0.99	5.96	2.98
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	254.97	17.05	24.36	21.65	17.86	16.24	20.30	1.35	11.64	5.14
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	154.60	7.93	57.35	12.47	19.04	11.33	10.43	4.53	7.03	3.17
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	219.31	9.80	37.40	11.76	13.06	12.41	10.12	1.63	15.19	3.59
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	97.69	33.72	22.05	12.21	13.12	10.02	10.57	4.19	5.83	1.82
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	110.86	8.49	66.30	21.75	16.97	13.79	7.96	4.77	5.83	2.65
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	124.26	7.80	57.63	9.60	14.41	9.00	8.40	4.20	7.80	6.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	538.21	51.20	21.00	36.10	29.21	28.22	27.24	3.61	30.85	11.81
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	145.22	4.88	28.78	8.29	12.36	10.41	10.73	3.42	6.18	2.28
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	109.71	27.16	18.34	9.52	9.35	12.88	10.41	5.12	4.76	4.41
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	113.22	7.03	42.19	13.36	13.36	15.47	5.63	4.22	4.92	4.22
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	182.96	7.82	44.13	15.17	15.17	15.17	6.44	3.68	8.27	2.30
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	160.67	6.11	27.31	8.03	13.18	16.39	13.50	1.61	9.00	4.50
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	325.92	45.18	14.49	30.01	20.35	16.55	35.52	3.10	17.59	10.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	594.18	326.17	2.53	22.76	5.06	42.98	126.42	2.53	12.64	15.17
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	114.51	19.83	12.25	8.47	6.02	12.25	10.69	4.01	4.90	2.90
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	179.09	5.93	37.68	14.82	12.28	9.31	8.04	2.12	8.04	4.23
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	212.90	11.87	25.63	16.14	16.85	8.54	8.78	1.66	14.00	2.61
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	99.59	3.00	18.46	5.58	11.16	9.01	9.87	4.72	3.86	2.58
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	370.14	1182.64	9.03	27.08	0.00	0.00	90.28	9.03	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	89.64	6.66	21.66	8.33	5.33	5.33	8.00	1.67	5.33	4.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	110.91	12.17	9.47	4.51	2.71	11.27	13.53	5.41	3.61	4.96
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	112.69	4.76	15.87	4.36	6.35	7.54	5.56	3.17	4.36	1.98
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	110.51	4.64	25.07	7.43	10.22	8.36	9.29	4.64	4.64	2.79
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	113.13	13.24	7.57	7.95	8.32	7.19	6.05	2.65	5.68	3.41
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	68.76	6.84	14.99	5.54	4.56	6.19	3.26	4.24	5.21	3.26
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	98.05	1.74	13.07	4.79	3.92	9.59	5.67	3.05	4.36	2.61
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	84.58	14.47	5.43	4.98	4.98	8.59	7.69	2.71	2.26	2.26
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	103.18	3.53	16.76	2.65	4.41	5.29	5.29	3.53	4.41	3.53
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	118.34	4.65	30.58	9.97	14.63	9.31	5.98	3.99	5.32	5.32
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	72.42	4.46	14.88	2.48	5.46	6.94	7.44	2.48	6.94	2.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	58.96	1.91	13.78	1.15	3.45	6.89	5.74	3.06	5.36	2.30
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	190.24	17.84	11.49	12.70	11.49	14.21	10.28	2.42	10.59	3.93
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	38.46	13.92	6.85	4.86	2.21	3.98	6.19	3.32	2.21	1.55
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	71.83	2.71	7.45	1.36	4.07	4.07	3.39	2.71	3.39	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	229.93	296.35	15.33	30.66	5.11	35.77	35.77	5.11	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	59.14	4.88	8.54	3.66	6.71	8.54	3.05	1.83	3.66	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	44.69	1.89	8.81	4.09	4.72	2.83	3.46	2.20	2.52	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	120.46	3.03	13.62	4.54	4.24	6.96	4.54	6.36	7.87	3.93
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	51.42	3.96	10.28	5.54	5.54	3.96	3.16	3.96	7.12	2.37
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	375.24	40.81	5.67	13.60	6.80	20.41	23.81	0.00	19.27	6.80
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	222.55	232.66	5.06	15.17	5.06	10.12	15.17	0.00	10.12	0.00
Myoblast, donor1	11241-116D8	16.03	22.24	31.68	12.67	12.80	3.60	1.74	1.74	1.12	1.74
Myoblast, donor2	11322-117D8	34.91	52.36	37.97	19.75	17.64	3.45	4.60	2.69	1.34	1.92
Myoblast, donor3	11398-118D3	34.98	29.76	35.65	14.80	12.11	5.21	2.35	3.36	1.68	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	0.00	0.31	0.31	0.31	0.00	0.31	0.00	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	0.18	0.18	0.00	0.00	0.18	0.18	0.00	0.37	0.00	0.00
Neural stem cells, donor1	11275-116H6	5.81	17.78	11.25	7.98	5.08	1.81	0.36	2.54	0.36	0.00
Neural stem cells, donor2	11352-117H2	9.63	26.96	17.33	5.78	7.70	1.93	0.00	0.00	0.00	1.93
Neurons, donor1	11494-119E9	20.48	28.45	11.38	5.69	6.83	6.83	0.00	3.41	2.28	0.00
Neurons, donor2	11574-120E8	10.57	15.41	6.60	5.28	1.54	3.96	1.54	1.54	0.44	1.10
Neurons, donor3	11655-122E8	60.02	12.33	9.87	9.87	11.51	16.44	5.76	1.64	6.58	0.00
Neutrophils, donor1	11233-116C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	83.00	115.05	28.50	33.84	22.08	8.43	6.29	2.49	4.99	2.61
Nucleus Pulposus Cell, donor2	11409-118E5	85.31	47.86	29.30	14.98	11.40	8.14	4.56	3.58	3.91	2.28
Nucleus Pulposus Cell, donor3	11462-119B4	42.12	58.76	21.46	6.02	1.80	3.21	12.63	2.01	2.01	1.00
Olfactory epithelial cells, donor1	11933-125I7	89.61	26.70	15.83	8.53	10.05	10.87	12.11	2.34	7.57	2.34
Olfactory epithelial cells, donor2	11934-125I8	95.82	26.63	25.19	11.72	15.78	12.45	9.99	1.88	6.66	1.45
Olfactory epithelial cells, donor3	11935-125I9	63.56	19.18	13.17	5.45	5.79	8.29	7.26	2.38	4.99	2.04
Olfactory epithelial cells, donor4	11936-126A1	89.61	24.64	6.04	5.26	3.02	11.01	9.06	3.12	5.84	1.95
Oligodendrocyte - precursors, donor1	11496-119F2	20.46	17.45	3.01	2.41	0.60	1.81	1.20	3.01	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	10.63	8.93	4.47	2.77	1.91	1.28	0.00	0.85	0.64	0.21
Osteoblast - differentiated, donor2	11353-117H3	0.00	2.29	0.00	1.14	2.29	1.14	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	6.21	9.31	5.59	3.10	3.72	2.48	1.24	1.86	0.62	1.86
Osteoblast, donor1	11277-116H8	15.05	24.63	9.58	6.45	5.47	2.93	0.39	0.39	1.17	0.39
Osteoblast, donor2	11354-117H4	38.63	43.54	18.26	11.24	9.13	5.62	4.21	2.81	4.21	3.51
Osteoblast, donor3	11426-118G4	13.33	21.86	10.49	4.44	3.91	1.24	0.36	0.71	1.24	0.71
Pancreatic stromal cells, donor1	11249-116E7	47.17	46.75	9.60	9.43	8.68	4.13	3.37	2.61	3.03	1.18
Pericytes, donor1	11491-119E6	8.34	14.91	1.34	1.22	0.33	0.78	2.34	0.56	0.78	0.33
Pericytes, donor2	11571-120E5	8.38	13.81	1.36	1.36	0.00	0.91	1.13	1.81	0.68	0.23
Pericytes, donor3	11652-122E5	14.44	20.14	2.24	3.87	1.63	1.42	2.44	1.22	1.22	0.61
Perineurial Cells, donor1	11499-119F5	22.60	30.06	3.05	3.05	1.81	2.60	1.70	2.26	1.92	0.23
Perineurial Cells, donor2	11579-120F4	16.47	14.72	6.62	4.78	3.22	1.56	1.38	1.47	0.74	0.83
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	1.27	0.64	0.32	0.00	0.00	0.32	0.00	0.00	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	0.49	0.24	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	1.16	0.26	0.52	0.00	0.13	0.13	0.00	0.13	0.13	0.13
Placental Epithelial Cells, donor1	11278-116H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	0.00	0.00	0.00	1.11	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	0.98	2.16	0.79	0.98	0.39	0.00	0.39	0.20	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	22.47	6.65	9.81	3.48	3.48	1.58	0.63	2.22	1.90	0.95
Preadipocyte - breast, donor1	11467-119B9	18.57	18.38	18.38	9.19	9.75	1.88	4.31	1.50	2.06	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	25.19	39.16	24.93	16.97	11.49	4.05	2.35	2.35	2.61	1.31
Preadipocyte - breast, donor2	11328-117E5	12.38	26.57	15.08	6.53	4.05	2.25	2.48	2.93	2.48	0.68
Preadipocyte - omental, donor1	11468-119C1	29.09	20.57	16.84	9.48	7.03	3.52	2.56	2.34	2.77	0.64
Preadipocyte - omental, donor2	11329-117E6	29.68	25.75	32.74	13.09	10.48	2.62	0.87	1.75	1.31	0.00
Preadipocyte - omental, donor3	11403-118D8	12.75	14.90	6.73	4.87	3.15	1.58	0.43	1.86	0.86	0.43
Preadipocyte - perirenal, donor1	11469-119C2	1.97	3.94	0.98	0.00	0.00	0.00	1.97	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	11.67	25.18	13.82	6.14	5.84	1.84	2.76	0.92	1.23	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	60.91	95.44	23.20	14.34	9.39	5.67	10.27	2.48	4.43	1.24
Preadipocyte - subcutaneous, donor3	11428-118G6	43.42	53.30	21.80	11.75	10.39	3.92	3.75	1.53	1.87	0.51
Preadipocyte - visceral, donor1	11280-116I2	79.73	76.19	47.13	22.45	18.82	6.15	4.56	2.24	4.56	1.12
Preadipocyte - visceral, donor2	11357-117H7	112.74	87.89	25.77	11.50	15.65	11.50	9.66	1.84	6.90	1.38
Preadipocyte - visceral, donor3	11429-118G7	51.62	45.98	38.24	8.05	4.70	3.34	5.85	0.94	2.19	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	12.67	19.31	1.06	0.75	0.75	1.51	1.06	2.72	0.60	0.91
Prostate Epithelial Cells, donor2	11331-117E8	7.85	13.27	1.76	2.57	0.81	0.41	1.08	1.90	1.35	0.14
Prostate Epithelial Cells, donor3	11404-118D9	12.06	13.96	1.35	1.59	1.10	2.33	1.04	2.63	0.80	0.98
Prostate Stromal Cells, donor1	11254-116F3	30.18	32.80	14.01	10.36	9.91	3.19	1.25	1.82	1.71	1.03
Prostate Stromal Cells, donor2	11332-117E9	33.89	62.22	13.09	9.14	6.28	3.77	9.32	1.97	2.69	2.15
Prostate Stromal Cells, donor3	11405-118E1	12.41	15.43	4.59	3.86	2.71	1.56	1.15	1.25	1.77	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	12.77	15.33	2.55	0.73	1.46	1.46	0.73	0.73	0.73	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	21.49	21.21	3.47	2.01	2.70	2.77	1.25	1.39	1.25	1.18
Renal Epithelial Cells, donor1	11517-119H5	9.64	18.77	2.54	0.51	4.06	1.01	1.52	1.52	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	22.05	17.07	1.42	2.85	2.13	1.42	1.42	2.13	2.13	0.00
Renal Epithelial Cells, donor3	11678-122H4	28.58	33.45	6.88	4.55	2.96	2.86	1.27	2.01	2.75	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	8.85	12.26	25.19	1.36	0.00	0.00	3.40	1.36	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	12.26	15.63	22.51	2.56	2.29	0.81	3.64	1.89	0.67	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	53.73	27.31	41.74	5.77	9.10	4.22	9.77	3.11	5.11	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	9.32	4.66	29.94	2.00	2.66	2.00	2.00	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	34.77	29.05	8.36	6.38	3.08	3.08	2.86	1.32	2.20	0.66
Renal Mesangial Cells, donor2	11598-120H5	31.98	22.57	3.76	2.51	1.88	3.13	2.51	1.88	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	11.37	11.93	2.22	1.94	0.55	1.94	1.94	1.11	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	22.01	22.82	1.61	2.42	0.27	1.88	1.34	2.42	2.42	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	10.54	13.92	0.00	0.84	0.00	2.53	0.00	0.00	0.84	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	19.67	23.72	5.01	2.12	3.28	2.12	1.54	1.16	0.96	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	1.30	2.85	0.26	0.78	0.26	0.00	0.78	0.26	0.26	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	3.13	5.68	0.57	0.28	0.28	0.00	0.28	1.14	0.57	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	5.15	3.09	0.00	1.03	0.00	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	6.52	5.52	0.50	0.25	0.50	0.25	0.75	0.00	0.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	26.59	24.32	46.51	10.56	13.23	2.54	1.60	2.41	1.74	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	11.61	3.57	1.79	0.89	0.00	0.00	0.00	0.89	0.00	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	6.05	8.81	3.85	2.75	0.00	3.85	1.10	0.00	0.55	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	4.06	4.64	2.32	1.16	1.74	0.00	0.00	0.58	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	15.21	18.72	6.11	2.21	1.30	2.60	3.77	1.17	1.17	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	12.12	11.22	2.68	2.98	2.58	2.68	1.09	1.59	0.99	1.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	11.49	13.05	4.80	3.90	2.68	1.67	1.12	1.78	0.78	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	6.70	22.58	4.59	3.85	2.11	0.37	2.48	1.24	0.62	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	11.19	12.70	3.15	3.85	2.21	2.10	2.80	0.93	0.47	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	12.02	13.64	3.93	2.54	2.31	2.54	2.31	1.16	0.69	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	7.12	11.36	4.52	2.05	0.55	0.96	2.88	1.23	0.27	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	12.71	11.35	3.18	3.18	2.27	2.12	2.12	1.66	0.91	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	10.57	12.01	3.40	3.05	2.51	3.58	1.61	1.08	0.72	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	7.89	11.33	5.02	2.01	1.15	0.72	3.16	1.58	0.29	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	10.19	12.77	3.00	3.00	2.58	1.40	2.25	1.18	0.32	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	9.29	8.63	2.21	2.21	1.33	1.55	2.43	1.11	1.11	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	10.32	8.03	4.78	2.49	0.38	1.15	1.15	1.72	0.19	2.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	12.86	9.41	2.14	2.89	1.58	2.70	1.96	1.77	1.21	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	10.90	12.78	3.95	3.01	3.01	2.25	0.75	0.19	1.50	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	9.29	9.02	4.38	1.59	0.27	1.46	3.32	0.80	0.40	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	13.43	10.71	2.73	2.92	2.92	2.34	1.75	1.85	0.88	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	9.74	10.69	3.06	2.48	2.86	1.53	2.86	2.10	0.95	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	9.72	8.97	4.38	1.07	0.96	0.32	2.78	1.82	0.21	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	13.73	15.70	2.80	3.36	2.24	2.52	1.12	1.68	0.56	1.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	11.62	11.28	2.91	1.88	2.05	2.22	2.05	1.54	0.17	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	12.95	7.84	3.83	1.82	0.36	0.55	2.55	1.64	0.18	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	8.95	12.88	3.43	2.58	2.45	1.96	2.08	1.96	0.12	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	8.60	9.54	2.42	2.55	1.61	1.75	1.61	0.67	0.40	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	11.09	10.85	7.78	1.89	0.94	0.94	1.42	1.18	0.47	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	13.69	12.30	2.18	3.17	1.98	2.58	1.79	0.60	0.60	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	8.89	12.86	4.21	2.57	1.64	2.57	3.74	1.17	0.70	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	7.88	8.71	3.53	2.49	0.41	0.62	1.24	1.45	0.21	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	15.71	11.28	4.20	3.54	1.55	3.76	2.21	1.55	0.66	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	11.49	11.07	3.13	3.13	2.30	1.88	1.04	1.25	0.84	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	6.46	10.09	4.71	2.15	0.94	1.35	2.02	1.88	0.27	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	14.65	9.03	2.55	1.70	1.70	3.92	3.07	1.36	0.68	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	14.07	9.83	5.01	2.31	2.51	2.51	1.54	0.96	0.58	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	6.53	10.32	4.47	2.24	0.86	0.86	0.52	1.55	0.86	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	15.36	8.92	2.47	3.70	1.51	2.88	2.61	1.51	0.55	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	10.18	8.70	2.30	2.13	2.13	2.96	2.63	1.31	0.16	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	11.42	11.42	5.62	1.87	1.19	0.85	1.87	1.53	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	8.73	11.24	3.85	3.85	2.66	2.66	0.74	2.52	0.30	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	11.20	6.66	1.87	2.40	0.80	3.20	0.53	0.27	0.00	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	7.33	7.60	5.12	1.94	0.69	0.55	1.24	0.97	0.41	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	4.29	7.86	1.43	2.14	0.48	0.95	0.71	1.43	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	6.85	4.03	1.01	1.21	1.21	1.61	1.41	1.41	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	2.64	6.31	2.26	0.85	0.19	0.47	0.85	0.75	0.19	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	6.99	6.99	1.75	1.05	0.70	0.35	1.05	0.35	0.35	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	4.23	5.74	2.12	0.60	0.91	0.60	0.60	0.60	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	4.65	4.53	2.45	0.73	0.49	0.61	0.98	0.37	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	7.71	10.19	4.37	3.49	2.33	2.33	1.31	1.46	1.02	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	7.30	9.13	3.65	0.61	0.61	3.65	0.00	1.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	1.21	3.92	2.41	0.30	0.00	0.90	0.60	1.51	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	15.61	12.44	3.85	3.62	2.04	3.39	2.26	1.81	0.45	2.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	4.19	6.59	0.30	1.20	0.90	1.50	0.90	0.90	0.00	1.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	12.75	14.05	10.39	2.60	1.30	1.65	2.83	1.30	0.83	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	8.96	11.10	2.99	2.56	2.56	3.63	2.13	2.13	1.07	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	6.01	11.42	0.60	3.00	0.60	0.60	0.60	1.20	0.60	0.60
Schwann Cells, donor1	11498-119F4	15.61	21.06	3.39	1.88	0.75	1.32	2.44	1.88	0.56	0.94
Schwann Cells, donor2	11578-120F3	44.23	10.21	0.00	3.40	6.80	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	39.00	46.88	14.68	7.01	4.60	1.53	6.57	2.41	3.29	1.10
Sebocyte, donor1	11220-116B5	11.50	22.46	2.74	1.64	0.00	0.00	1.10	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	5.51	6.43	0.92	0.46	0.00	1.38	0.46	0.46	0.92	0.00
Sebocyte, donor3	11378-118B1	24.53	16.49	2.06	3.50	2.47	3.09	1.03	1.86	1.65	0.62
Sertoli Cells, donor1	11255-116F4	24.85	54.67	4.97	8.28	4.97	8.28	3.31	6.63	4.97	0.00
Sertoli Cells, donor2	11333-117F1	16.95	33.89	8.47	2.82	0.00	0.00	2.82	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	116.39	95.63	49.62	24.90	21.03	11.26	9.59	2.20	6.42	2.82
Skeletal Muscle Cells, donor2	11358-117H8	7.95	9.40	3.61	2.89	2.89	0.72	0.00	0.00	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	10.87	35.11	8.36	5.02	3.34	0.84	8.36	1.67	0.00	1.67
Skeletal Muscle Cells, donor4	11451-119A2	29.69	45.24	15.24	8.80	3.14	3.14	8.33	1.26	1.26	0.94
Skeletal Muscle Cells, donor5	11455-119A6	26.16	35.23	11.89	8.47	3.42	2.82	4.01	1.78	2.68	0.89
Skeletal Muscle Cells, donor6	11459-119B1	37.86	42.63	11.08	4.31	1.39	5.54	7.08	2.00	2.62	1.23
Skeletal Muscle Satellite Cells, donor1	11240-116D7	70.19	77.49	16.63	17.64	9.45	10.84	2.77	2.02	5.29	1.26
Skeletal Muscle Satellite Cells, donor2	11321-117D7	29.39	48.94	9.27	11.70	9.85	4.14	4.71	0.86	2.43	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	43.75	51.39	12.60	10.12	9.13	5.65	5.36	2.38	4.07	1.09
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	45.92	44.91	14.49	9.86	6.82	4.80	3.54	1.18	3.62	0.93
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	20.99	44.87	14.48	10.86	2.17	2.90	2.17	1.45	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	15.00	25.18	26.28	5.09	3.58	1.10	2.06	0.96	0.83	0.83
Skin - palm, donor1	10286-104F7	10.74	2.69	16.12	0.00	5.37	0.00	0.00	0.00	2.69	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	5.62	1.59	1.15	0.29	0.43	1.01	0.00	2.59	0.58	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	6.54	3.27	6.54	3.27	3.27	0.00	0.00	5.73	0.82	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	6.62	1.30	1.17	0.91	0.26	0.39	0.52	1.04	0.13	1.43
Small Airway Epithelial Cells, donor1	11256-116F5	15.15	17.79	2.78	2.78	1.39	1.81	1.25	2.92	0.83	1.53
Small Airway Epithelial Cells, donor2	11334-117F2	16.88	12.52	3.66	1.83	2.53	2.39	2.67	2.95	1.13	1.55
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	11.63	20.93	8.46	5.29	3.17	1.90	1.06	4.65	2.54	1.27
Small Airway Epithelial Cells, donor3	11406-118E2	17.24	12.22	3.00	2.02	1.65	4.05	1.12	4.87	1.12	0.75
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	5.55	4.63	3.39	0.62	0.62	0.00	1.85	0.62	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	85.38	107.16	208.32	35.80	21.12	6.45	24.01	8.00	4.45	3.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	41.15	57.02	36.45	22.93	11.17	2.35	1.18	1.76	2.35	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	48.18	54.36	28.29	14.81	10.39	5.08	3.98	1.77	7.29	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	24.02	26.78	27.17	10.63	10.24	3.15	1.18	0.00	1.97	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	45.58	57.17	60.26	17.00	14.68	4.64	5.41	3.09	3.09	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	37.03	31.02	13.01	12.01	2.00	3.00	4.00	3.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	32.74	35.13	23.95	9.32	9.32	1.73	1.60	1.33	2.93	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	78.69	108.17	46.99	19.73	14.63	9.09	11.97	3.32	6.21	1.99
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	10.63	16.26	19.59	5.38	2.69	1.28	4.10	2.05	0.90	1.02
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	16.61	22.14	4.88	2.28	2.28	0.98	0.98	1.30	1.63	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	43.12	39.28	10.04	5.32	5.02	5.02	1.77	2.07	4.43	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	13.81	12.96	1.85	1.99	1.28	2.14	1.00	1.00	1.71	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	10.57	8.62	2.44	1.63	0.98	1.14	0.33	0.81	0.33	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	31.66	27.70	12.18	7.31	7.92	4.57	5.18	2.44	1.83	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	64.40	66.17	53.80	23.49	24.25	5.30	5.05	2.78	5.05	1.26
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	12.24	42.84	18.36	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	15.26	16.69	10.01	1.91	2.38	1.43	3.34	0.48	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	18.43	24.63	3.69	2.95	2.06	2.95	2.06	1.62	1.03	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	19.59	22.38	2.80	4.74	1.51	2.58	3.44	0.86	0.65	1.51
Smooth Muscle Cells - Colonic, donor3	11396-118D1	26.66	23.30	5.04	3.78	2.73	4.62	0.94	2.10	1.36	1.57
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	16.71	32.79	34.34	13.61	12.22	2.78	2.17	1.08	0.93	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	9.70	19.40	17.25	3.23	7.55	0.00	2.16	1.08	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	19.13	28.39	17.63	5.98	3.59	1.79	4.18	1.79	0.90	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	5.80	5.46	1.02	0.68	0.00	1.37	0.34	0.34	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	24.34	33.14	1.73	2.83	2.12	3.30	0.71	2.36	1.49	0.79
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	54.75	51.83	47.40	20.73	17.91	4.93	5.84	4.23	4.43	1.21
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	54.61	103.54	34.59	14.56	15.47	4.10	9.33	3.19	6.14	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	11.47	34.42	15.70	2.42	1.81	0.60	4.23	1.21	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	26.49	32.06	5.83	8.21	2.38	3.44	3.71	1.85	3.71	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	35.95	37.55	24.63	5.99	2.53	3.46	9.32	2.40	2.26	1.07
Smooth Muscle Cells - Prostate, donor2	11335-117F3	16.40	28.55	9.14	3.76	2.88	2.13	3.51	2.13	0.88	1.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	37.03	39.32	15.98	13.70	5.33	4.31	3.55	1.78	1.52	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	84.73	63.02	62.12	25.33	25.18	8.14	7.39	2.26	4.98	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	21.00	47.26	23.26	15.00	18.00	2.25	3.75	3.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	28.43	32.31	25.84	10.34	0.00	5.17	5.17	1.29	11.63	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	35.81	41.86	25.58	14.42	8.37	0.93	2.33	3.72	3.72	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	42.91	59.58	44.93	19.19	20.70	7.07	7.07	4.04	3.03	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	23.50	35.41	38.86	7.83	5.01	0.94	4.39	0.94	0.94	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	7.67	7.37	5.01	1.47	2.06	0.29	0.00	0.29	1.18	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	52.90	57.56	17.99	14.91	8.25	6.16	2.42	3.00	4.08	1.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	27.10	28.03	8.88	9.34	4.67	4.67	3.74	3.27	1.40	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	18.71	20.87	10.79	4.75	4.32	1.73	1.44	1.58	1.58	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	16.57	20.14	12.24	4.84	5.35	2.29	3.31	1.78	1.53	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	14.10	30.27	12.97	3.38	3.20	2.07	3.01	0.94	0.75	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	40.81	56.32	10.76	8.24	4.61	4.19	3.21	4.61	3.77	2.52
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	27.40	38.96	4.69	3.44	1.84	3.18	3.35	2.93	2.51	1.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	14.29	11.90	1.90	0.48	0.48	2.86	1.43	1.90	0.48	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	11.50	20.31	9.30	5.14	5.14	1.96	0.00	0.98	0.49	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	59.21	39.11	32.04	9.28	2.43	9.94	15.47	1.77	3.54	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	94.50	65.83	27.79	12.00	8.48	12.58	5.56	1.17	6.14	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	108.45	31.68	11.08	10.30	6.03	11.66	3.89	3.69	5.05	1.55
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	40.99	20.63	26.45	9.78	10.05	4.23	1.32	1.85	1.85	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	70.67	35.33	46.12	23.06	18.97	6.70	1.86	1.86	2.98	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	31.98	26.59	28.03	9.34	4.67	4.67	1.44	3.59	1.44	1.80
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	30.95	11.07	23.00	8.23	8.23	4.54	1.14	1.42	1.42	1.42
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	74.05	20.88	27.96	5.91	5.91	5.12	2.76	2.76	4.33	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	77.71	33.27	37.33	14.48	14.22	9.65	2.54	3.56	3.05	1.52
Smooth muscle cells - airway, control, donor2	11967-126D5	137.77	44.72	25.56	16.77	9.58	14.38	5.99	3.59	6.79	2.40
Smooth muscle cells - airway, control, donor3	11968-126D6	50.58	22.57	17.97	6.27	5.43	5.02	1.67	2.09	3.34	2.09
Smooth muscle cells - airway, control, donor4	11969-126D7	40.34	16.50	5.04	6.42	1.38	4.58	1.83	1.83	2.75	1.83
Synoviocyte, donor1	11291-117A4	17.84	25.58	11.11	8.42	4.04	1.51	2.02	1.51	2.02	0.84
Synoviocyte, donor2	11368-117I9	11.57	16.26	7.38	5.87	4.69	1.84	1.68	2.51	1.68	0.67
Synoviocyte, donor3	11440-118H9	16.76	20.55	10.28	3.35	1.34	1.12	5.36	2.68	0.45	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	37.16	26.09	6.07	6.43	0.71	3.57	3.93	3.93	2.14	1.43
Trabecular Meshwork Cells, donor2	11612-122A1	13.87	19.82	0.00	0.00	0.00	3.96	0.00	1.98	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	29.64	24.31	3.24	4.40	4.17	3.94	2.78	1.85	1.39	1.39
Tracheal Epithelial Cells, donor1	11292-117A5	4.37	11.61	1.36	0.43	0.43	0.86	0.43	0.65	0.14	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	3.87	3.48	1.16	0.00	1.55	0.77	0.39	1.55	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	1.15	3.44	0.57	1.72	0.57	0.00	0.00	1.15	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	24.11	20.91	42.32	10.09	12.43	3.69	1.97	3.08	2.21	0.62
Urethra, donor2	10319-105A4	50.36	12.59	16.19	5.40	7.19	5.40	5.40	1.80	7.19	0.00
Urothelial Cells, donor1	11520-119H8	6.91	4.25	0.00	0.27	0.00	1.33	0.53	0.80	0.80	0.27
Urothelial Cells, donor2	11600-120H7	3.20	4.81	0.40	0.00	0.40	1.20	0.80	0.40	0.00	0.40
Urothelial Cells, donor3	11681-122H7	1.83	4.13	0.46	0.23	0.00	0.46	0.23	0.00	0.46	0.00
Urothelial cells, donor0	11216-116B1	10.03	13.60	0.67	0.45	0.45	2.23	0.67	0.45	0.45	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	0.00	0.00	3.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	2.86	1.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	0.00	0.68	0.68	0.00	0.00	0.00	0.68	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	0.00	0.00	0.00	0.00	0.34	0.00	0.00	0.69	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	0.00	0.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	1.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	0.92	0.92	0.92	0.00	0.00	0.00	0.00	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	5.30	3.33	2.84	1.73	0.49	0.99	0.25	0.12	0.62	0.12
Wilms' tumor cell line:HFWT	10597-108E3	3.52	0.00	0.00	0.00	0.00	0.00	0.88	1.76	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	6.70	3.07	0.28	0.28	0.00	1.68	0.56	1.68	0.00	0.56
achilles tendon, donor2	10292-104G4	24.80	10.33	37.20	2.07	8.27	0.00	4.13	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.47	0.47	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	0.54	0.54	0.00	0.00	0.00	0.00	0.00	0.00	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	0.00	0.00	0.00	0.00	0.00	0.00	0.28	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	7.08	8.17	22.32	4.08	4.63	0.27	0.00	0.82	0.27	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	0.00	0.44	0.88	0.00	0.44	0.00	0.00	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	0.82	0.00	1.23	0.00	0.00	0.00	0.41	1.63	0.00	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	1.55	1.55	0.39	0.00	0.00	0.39	0.00	1.16	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.74	1.10	1.10	0.18	0.92	0.37	0.18	1.10	0.18	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	0.00	0.23	0.00	0.00	0.23	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	5.44	5.70	1.55	1.81	1.04	0.78	0.78	3.62	0.78	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	1.75	2.34	0.58	0.00	0.58	0.88	0.00	1.17	0.58	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.00	0.00	2.88	0.00	0.00	0.00	0.41	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	0.31	0.00	0.61	0.61	0.31	0.00	0.00	0.61	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	1.71	0.43	0.00	0.00	0.43	0.00	0.43	1.71	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	1.21	1.82	0.30	0.61	0.00	0.00	0.00	1.21	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	0.24	0.96	0.24	0.00	0.24	0.00	0.00	0.96	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	0.00	0.45	2.67	0.45	0.22	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	1.33	0.67	0.00	0.00	0.00	0.67	0.00	0.33	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	0.00	0.00	0.38	0.00	0.00	0.00	0.38	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	25.73	18.75	3.93	2.62	3.93	3.05	6.54	4.36	2.18	11.78
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	0.00	0.00	0.00	1.87	0.00	0.00	0.00	3.75	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	1.65	3.77	0.00	0.00	0.47	0.94	0.47	5.89	0.71	0.24
adipose tissue, adult, pool1	10010-101C1	21.25	13.81	167.99	17.06	36.45	1.40	1.40	2.79	1.86	0.93
adipose, donor1	10184-103D4	1.76	9.38	0.00	0.00	0.00	1.76	0.59	0.59	0.00	0.00
adipose, donor2	10185-103D5	13.79	3.24	1.62	0.41	0.41	2.43	1.62	1.62	0.81	0.41
adipose, donor3	10186-103D6	14.70	12.80	0.82	5.99	1.63	2.72	1.36	1.09	0.82	0.00
adipose, donor4	10187-103D7	11.27	40.74	0.00	13.00	0.87	1.73	0.00	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	0.00	0.00	0.00	0.00	0.16	0.00	0.00	0.00	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	29.10	3.64	14.55	10.91	3.64	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	10.36	7.50	4.29	1.43	3.22	1.07	1.43	1.07	0.00	1.07
amniotic membrane cells, donor1	12235-129G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	0.34	3.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	3.56	0.00	7.11	2.37	3.56	0.00	0.00	3.56	0.00	0.00
amygdala, adult, donor10252	10151-102I7	2.84	6.08	5.27	2.43	2.64	0.41	0.61	1.42	1.22	0.41
amygdala, newborn, donor10223	10360-105E9	16.14	6.13	10.33	2.26	2.58	4.84	1.94	1.61	1.94	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	76.14	88.62	9.04	5.09	2.93	9.80	5.98	8.02	2.16	4.46
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.00	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	0.67	0.67	0.00	0.00	0.00	0.33	0.33	0.33	0.00	0.00
aorta, adult, pool1	10052-101G7	15.30	11.77	25.50	5.10	8.63	1.96	0.39	3.33	0.98	1.18
appendix, adult	10189-103D9	13.97	8.54	29.89	6.21	9.70	1.16	2.72	1.55	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	0.34	4.13	0.00	0.00	0.00	0.00	0.00	1.03	0.34	1.03
artery, adult	10190-103E1	8.15	5.43	29.89	6.79	6.79	0.00	1.36	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	9.42	13.33	1.01	1.16	0.14	1.16	0.43	2.32	0.43	0.87
b cell line:RPMI1788	10427-106D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	41.89	38.29	18.31	11.65	7.77	4.99	4.99	3.33	4.44	2.22
bile duct carcinoma cell line:HuCCT1	10432-106D9	36.62	33.54	14.19	8.34	8.63	4.27	3.37	1.19	1.49	0.79
bile duct carcinoma cell line:TFK-1	10496-107C1	21.09	24.10	6.36	9.37	4.18	3.68	3.51	6.03	1.00	1.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	0.56	0.00	0.00	0.00	0.00	0.56	0.00	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	22.38	9.67	29.22	6.19	10.86	3.26	1.20	1.09	1.20	0.76
blood, adult, pool1	10053-101G8	4.43	0.00	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	59.09	21.41	10.28	3.43	10.28	5.14	4.28	5.14	1.71	1.71
bone marrow, adult	10192-103E3	24.97	23.62	80.98	12.15	24.97	2.02	1.35	0.67	0.67	2.02
brain, adult, donor1	10084-102B3	6.15	1.03	8.20	0.00	1.03	1.03	0.00	2.05	0.00	1.03
brain, adult, pool1	10012-101C3	3.23	5.79	4.68	1.45	1.89	1.11	0.45	2.45	0.22	0.67
brain, fetal, pool1	10085-102B4	34.73	5.34	2.67	2.67	2.67	13.36	2.67	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	23.46	11.89	2.31	0.33	1.32	5.95	3.63	4.63	2.97	2.97
breast carcinoma cell line:MDA-MB-453	10419-106C5	0.12	0.25	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast, adult, donor1	10080-102A8	28.41	3.79	101.65	8.21	17.68	6.31	0.00	0.63	1.89	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	8.13	15.12	2.54	2.67	1.02	2.67	1.14	5.21	0.76	0.76
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	14.22	9.90	1.55	1.24	0.62	1.86	2.47	2.47	0.93	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	32.46	42.36	15.42	6.68	2.99	0.92	3.68	2.07	3.22	1.15
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	0.48	0.73	0.24	0.00	0.24	0.00	0.00	0.73	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	0.47	1.41	0.00	0.00	0.00	1.41	0.94	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	52.39	32.92	3.50	2.73	1.53	8.64	4.05	6.56	4.05	2.41
carcinoid cell line:SK-PN-DW	10719-109I8	11.41	7.61	0.00	0.32	0.63	3.80	1.90	1.90	1.27	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	7.45	6.92	1.60	2.40	1.60	0.80	0.27	0.00	0.27	0.80
caudate nucleus - adult, donor10196	10177-103C6	0.00	0.00	5.76	1.15	3.45	0.00	0.00	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	2.84	3.51	3.01	1.51	2.34	0.67	0.17	1.84	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	0.76	0.00	5.35	1.53	1.53	0.76	0.00	1.53	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	13.92	3.30	10.99	2.56	1.46	5.13	1.10	2.56	1.46	0.73
cerebellum - adult, donor10196	10173-103C2	0.00	0.00	0.00	0.00	2.91	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	0.43	0.21	5.34	0.43	1.07	0.21	0.21	0.00	0.21	0.00
cerebellum, adult, pool1	10083-102B2	0.34	0.34	2.41	0.00	0.00	0.00	0.00	0.00	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	3.32	2.49	10.79	0.00	3.32	0.00	1.66	2.49	0.83	0.00
cerebral meninges, adult	10188-103D8	4.79	4.29	3.53	1.01	1.51	0.50	0.50	1.51	0.25	0.25
cerebrospinal fluid, donor2	10294-104G6	11.69	1.46	12.43	0.00	2.19	0.73	0.73	1.46	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	0.14	0.00	0.00	0.00	0.00	0.14	0.14	0.00	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	12.26	13.75	3.65	0.50	0.50	3.15	0.50	1.49	1.99	0.83
cervix, adult, pool1	10013-101C4	37.80	19.74	31.50	7.56	11.97	7.35	2.83	3.36	3.78	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	80.96	66.88	20.20	13.79	8.22	13.38	10.31	2.51	2.93	5.02
chondrosarcoma cell line:SW 1353	10700-109G7	155.44	16.98	10.45	6.53	0.00	32.66	32.66	9.14	6.53	7.84
choriocarcinoma cell line:BeWo	10423-106C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	23.90	39.43	8.01	3.33	1.72	3.08	2.83	5.42	2.22	3.08
choriocarcinoma cell line:T3M-3	10618-108G6	16.60	32.02	27.04	6.88	4.98	1.19	2.13	8.30	1.19	0.00
chorionic membrane cells, donor1	12238-129G6	0.57	1.42	1.99	0.00	0.57	0.00	0.00	0.00	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	36.99	29.23	8.85	5.77	3.78	3.18	3.28	1.29	2.49	0.40
chorionic membrane cells, donor3	12240-129G8	0.55	3.85	2.75	0.55	0.00	0.00	0.00	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	2.02	1.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	15.18	12.49	10.76	2.88	4.23	2.88	2.50	2.69	1.15	1.34
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	0.84	0.21	0.42	0.00	0.21	0.21	0.00	1.27	0.42	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	0.29	0.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	1.82	0.78	0.26	0.00	0.00	0.00	0.00	0.52	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	10.29	26.74	0.91	1.14	0.46	1.37	2.06	2.29	0.46	1.60
clear cell carcinoma cell line:TEN	10636-108I6	3.82	4.86	0.69	0.87	0.52	0.69	0.35	0.52	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	35.33	30.38	2.93	2.38	2.01	3.29	2.56	4.39	1.65	1.28
colon carcinoma cell line:COLO-320	10420-106C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	20.23	5.95	16.66	1.19	5.95	1.19	1.19	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	11.87	11.63	38.54	6.35	9.75	2.00	1.18	2.23	0.47	0.00
colon, fetal, donor1	10070-101I7	28.43	6.18	40.17	6.18	9.27	1.24	0.62	0.62	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	3.82	5.10	1.70	0.42	0.00	0.42	0.85	0.42	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	0.60	0.91	0.00	0.00	0.00	0.15	0.30	0.30	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	0.56	1.83	0.00	0.28	0.00	0.00	0.14	0.42	0.28	0.42
corpus callosum, adult, pool1	10042-101F6	1.77	3.43	3.87	0.88	2.32	0.33	0.22	1.44	0.22	0.66
cruciate ligament, donor2	10295-104G7	34.04	10.54	59.16	10.54	17.83	7.29	5.67	0.81	2.43	2.43
diaphragm, fetal, donor1	10069-101I6	75.44	24.88	126.80	12.04	14.45	10.43	1.61	4.82	4.01	1.61
diencephalon, adult	10193-103E4	1.68	1.92	1.92	0.72	0.24	0.00	0.24	1.68	0.00	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	1.28	1.28	0.26	0.26	0.00	0.51	0.00	0.26	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	0.48	1.20	0.00	0.24	0.00	0.24	0.00	0.00	0.00	0.00
ductus deferens, adult	10196-103E7	12.96	18.44	10.47	9.97	8.97	2.49	3.49	1.99	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	87.85	15.84	57.61	5.76	11.52	5.76	7.20	1.44	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	41.93	24.28	52.23	4.41	5.15	6.62	5.15	2.94	1.47	0.00
dura mater, adult, donor1	10041-101F5	33.53	37.82	115.13	17.51	32.37	4.54	3.39	4.54	2.48	1.57
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	6.00	4.22	2.89	0.67	1.11	0.00	1.33	0.67	0.89	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	15.91	17.34	4.01	3.58	2.01	1.15	2.01	1.15	1.86	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	20.96	6.17	1.23	0.62	0.62	3.08	4.32	1.23	0.62	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	2.42	2.12	0.00	0.30	0.00	0.30	0.30	2.12	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	22.23	6.17	2.47	0.93	0.93	2.47	2.78	5.25	1.85	3.09
embryonic pancreas cell line:2C6	10603-108E9	17.08	5.25	0.00	1.31	1.31	1.31	0.00	2.63	0.00	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	0.00	0.34	0.00	0.00	0.34	0.00	0.00	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	3.26	2.90	1.09	0.72	0.36	0.72	0.36	0.72	0.36	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	0.00	0.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	5.89	8.11	1.33	0.44	0.44	0.78	0.89	3.00	0.67	1.45
epidermoid carcinoma cell line:Ca Ski	10431-106D8	3.08	6.16	0.33	0.44	0.33	0.55	0.22	1.54	0.11	1.43
epididymis, adult	10197-103E8	19.26	22.19	27.00	8.37	10.88	1.88	2.72	1.05	2.09	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	77.71	32.11	9.23	7.45	4.97	10.64	5.14	1.60	5.32	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	1.57	0.39	0.00	0.39	0.39	0.00	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	3.80	5.64	1.18	0.39	0.13	0.13	1.97	1.44	0.66	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	6.79	13.19	1.48	0.69	0.30	1.97	2.07	2.26	0.79	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	6.27	6.95	1.34	1.01	0.34	0.90	1.01	1.57	0.34	0.22
esophagus, adult, pool1	10015-101C6	10.30	6.80	22.93	4.25	7.33	1.17	0.96	0.64	0.96	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	0.13	0.13	0.13	0.00	0.38	0.00	0.00	0.00	0.13	0.00
eye - muscle inferior rectus, donor1	10272-104E2	43.46	12.07	65.19	21.73	9.66	4.83	7.24	4.83	4.83	2.41
eye - muscle lateral, donor2	10298-104H1	39.98	8.42	10.52	0.00	2.10	4.21	4.21	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	102.69	8.93	20.84	1.49	7.44	7.44	4.46	2.98	2.98	0.00
eye - muscle superior, donor2	10297-104G9	85.99	9.17	35.54	8.03	11.46	5.73	4.59	3.44	6.88	0.00
eye - vitreous humor, donor1	10268-104D7	10.20	4.37	4.37	1.46	2.91	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	25.93	10.17	26.44	5.59	7.12	4.83	2.54	0.51	0.76	1.27
fibrosarcoma cell line:HT-1080	10758-110E2	112.84	69.11	26.67	19.49	14.10	18.85	7.31	7.57	5.39	1.92
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	98.77	59.12	12.58	5.94	5.94	12.11	12.58	7.60	3.80	3.80
frontal lobe, adult, pool1	10040-101F4	3.00	8.07	3.75	1.50	1.69	0.66	0.56	2.44	0.47	0.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	1.80	2.70	0.30	0.00	0.00	0.30	0.30	0.00	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	61.45	59.43	18.01	19.02	13.17	6.67	3.20	4.75	1.19	3.11
gall bladder, adult	10198-103E9	21.49	16.18	28.97	8.21	11.83	1.21	1.45	2.17	1.21	0.72
gamma delta positive T cells, donor1	11937-126A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	3.36	0.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	13.31	10.98	2.75	2.53	0.63	1.48	1.90	0.21	0.00	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	9.09	12.77	1.55	0.97	1.16	1.93	1.55	2.90	0.39	0.77
gastric cancer cell line:AZ521	10549-107H9	0.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	5.94	5.25	0.23	0.00	0.00	0.46	0.69	2.28	0.23	2.06
giant cell carcinoma cell line:LU65	10487-107B1	29.03	28.23	2.75	2.07	1.49	3.67	3.67	5.97	1.95	1.95
giant cell carcinoma cell line:Lu99B	10433-106E1	25.47	31.07	5.46	5.88	1.68	3.92	1.82	2.10	3.08	1.40
glassy cell carcinoma cell line:HOKUG	10688-109F4	2.00	4.99	0.25	0.25	0.25	0.50	0.75	2.49	0.50	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	89.40	58.05	8.13	5.59	4.64	11.82	7.07	2.22	7.07	1.16
glioblastoma cell line:A172, tech_rep2	10444-106F3	127.66	43.68	10.11	6.04	5.76	21.49	10.53	3.23	8.85	2.25
glioblastoma cell line:T98G	10485-107A8	44.59	28.48	6.73	6.84	4.08	4.97	3.42	1.88	1.66	2.21
glioma cell line:GI-1	10413-106B8	18.45	12.30	2.05	2.34	1.76	3.22	2.05	0.88	1.17	0.88
globus pallidus - adult, donor10196	10175-103C4	1.46	1.46	3.64	0.00	2.92	0.00	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	2.20	1.71	7.32	1.95	3.42	0.00	0.24	0.49	0.24	0.00
globus pallidus, adult, donor10258	10367-105F7	1.37	1.37	0.00	0.00	0.00	1.37	0.00	1.37	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	7.99	2.13	19.19	2.13	5.33	2.66	0.53	3.73	1.07	2.13
granulocyte macrophage progenitor, donor1	12131-128D7	0.00	0.00	2.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	14.40	15.36	0.64	2.24	0.64	3.52	1.28	2.56	1.60	1.92
hIPS +CCl2, biol_rep1	14383-156B9	8.26	5.51	2.30	0.92	0.92	0.92	0.00	1.38	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	5.03	3.20	0.46	0.00	0.00	2.29	0.00	1.37	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	4.51	1.93	2.58	0.00	0.00	0.64	0.00	3.86	1.29	0.00
hIPS, biol_rep1	14380-156B6	4.31	4.31	1.44	2.87	0.00	1.44	0.00	2.87	0.00	0.00
hIPS, biol_rep2	14381-156B7	8.23	2.74	1.37	0.69	0.00	0.69	0.00	2.74	0.00	0.00
hIPS, biol_rep3	14382-156B8	2.21	2.21	2.21	1.10	0.00	0.00	0.00	1.10	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	16.44	13.75	37.37	10.16	16.74	2.39	3.89	2.39	0.30	0.60
heart - pulmonic valve, adult	10206-103F8	20.66	20.92	55.96	14.12	16.73	3.14	3.40	6.54	1.31	0.78
heart - tricuspid valve, adult	10207-103F9	19.98	10.82	83.26	20.82	21.65	7.49	5.83	1.67	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	14.90	9.59	26.32	6.53	8.57	2.24	1.22	2.86	2.04	0.41
heart, adult, diseased, donor1	10051-101G6	35.77	19.16	38.75	8.52	12.77	5.54	1.28	7.24	3.41	0.85
heart, adult, pool1	10016-101C7	21.16	23.69	49.22	10.12	14.03	1.61	1.84	5.06	1.15	0.46
heart, fetal, pool1	10046-101G1	57.60	63.87	82.55	17.76	21.25	6.47	3.80	7.60	3.18	3.59
hepatic mesenchymal tumor cell line:LI90	10778-110G4	41.96	17.59	4.01	0.62	0.62	6.48	0.93	1.85	1.23	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	0.00	0.00	0.00	0.00	0.00	1.19	0.00	3.57	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	2.65	4.09	0.22	0.55	0.00	0.44	0.77	1.77	0.22	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	3.28	6.68	0.36	0.24	0.12	0.24	0.97	1.82	0.00	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	2.22	5.15	0.20	0.40	0.00	0.30	0.40	2.43	0.30	0.40
hepatoma cell line:Li-7	10484-107A7	56.50	30.81	10.68	11.57	9.12	6.56	5.12	1.89	2.22	1.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	21.77	24.60	18.93	7.57	5.68	11.36	2.84	6.62	0.95	2.84
hippocampus, adult, donor10252	10153-102I9	11.63	11.63	7.55	2.65	2.65	4.29	2.65	2.25	1.02	0.00
hippocampus, adult, donor10258	10374-105G5	3.98	2.49	2.49	0.50	0.50	0.50	0.00	3.49	0.00	1.00
hippocampus, newborn, donor10223	10363-105F3	94.46	22.91	23.97	10.22	12.34	16.57	5.64	4.58	14.10	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	1.22	0.00	0.00	0.61	0.61	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	0.39	0.39	0.20	0.00	0.00	0.20	0.00	0.59	0.00	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	1.02	0.25	0.00	0.00	0.25	0.25	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	1.69	0.00	0.00	0.00	0.00	1.13	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	1.29	0.52	0.00	0.00	0.00	0.00	0.00	0.52	0.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	0.76	0.00	0.38	0.00	0.00	0.00	0.38	0.38	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	10.80	3.80	0.29	0.29	0.00	2.04	0.29	0.88	0.88	1.75
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	10.56	4.95	0.22	0.65	0.86	1.08	1.29	1.08	0.22	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	13.76	3.34	1.67	0.42	1.25	2.92	0.42	0.83	1.67	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	10.42	5.68	2.13	1.89	0.71	2.13	1.18	1.18	1.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	17.68	6.11	1.77	0.80	0.48	2.09	1.93	2.41	0.48	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	22.89	8.08	0.67	2.02	0.00	4.04	1.35	2.02	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	1.41	0.63	0.16	0.00	0.00	0.16	0.31	0.31	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	0.98	0.49	0.00	0.00	0.00	0.49	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	0.00	0.87	0.87	0.00	0.87	0.87	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	1.72	1.72	0.19	0.00	0.19	0.19	1.15	0.00	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	1.74	0.87	0.00	0.00	0.44	1.31	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	8.00	1.00	0.00	0.00	0.50	1.00	0.00	0.50	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	6.03	3.96	0.94	0.75	0.57	1.32	0.75	0.57	0.57	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	5.00	6.37	0.45	0.45	0.91	0.91	1.36	1.82	0.91	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	11.90	5.95	0.94	0.94	0.31	2.51	0.31	3.45	0.31	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	11.92	8.17	1.96	1.31	0.82	1.47	1.47	1.14	1.47	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	11.61	6.39	0.58	1.45	2.03	2.90	0.29	1.16	1.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	21.52	8.07	2.39	0.60	0.60	1.20	0.30	1.20	0.90	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	1.48	1.66	0.37	0.00	0.00	0.18	0.37	0.55	0.18	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	0.86	0.29	0.57	0.00	0.00	0.57	0.29	0.00	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	4.08	1.63	0.41	0.41	0.41	0.41	0.41	0.82	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	4.93	2.82	1.06	0.00	0.35	0.35	0.35	0.00	0.70	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	6.33	2.22	0.32	0.00	0.32	0.32	0.32	0.00	0.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	7.26	2.12	1.21	0.30	0.00	0.91	0.61	0.61	0.30	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	15.00	6.21	3.10	0.00	0.00	2.07	3.10	2.59	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	25.90	12.62	4.65	1.99	1.33	1.99	1.99	2.66	1.99	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	9.24	5.39	1.80	0.51	1.28	1.03	0.77	1.28	0.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	7.93	4.09	2.56	0.51	0.00	0.51	1.02	0.77	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	19.69	6.06	2.27	2.27	2.27	6.06	1.51	1.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	16.13	6.39	3.70	3.02	1.01	2.69	0.67	1.34	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	0.72	0.72	0.00	0.00	0.24	0.72	0.48	0.24	0.24	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	3.12	0.89	0.00	0.00	0.45	0.89	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	2.93	1.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	2.75	1.83	0.31	0.00	0.00	0.61	0.61	0.00	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	0.00	3.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	1.65	1.65	0.00	0.33	0.00	1.32	0.00	0.33	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	9.85	1.09	0.00	1.09	0.55	0.55	1.09	0.55	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	6.15	3.26	1.81	0.36	1.45	0.36	0.00	0.72	0.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	4.63	1.78	0.00	1.07	0.36	1.42	0.00	1.78	1.07	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	15.51	1.19	0.00	0.00	1.19	1.19	2.39	2.39	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	9.07	4.47	1.76	1.49	0.95	0.95	0.95	1.49	0.95	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	10.51	4.31	0.81	0.27	0.81	1.35	1.08	0.27	0.54	0.00
immature langerhans cells, donor1	11904-125F5	0.73	0.48	4.36	0.73	1.45	0.00	0.00	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	0.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	3.79	7.95	4.45	1.23	2.08	1.04	0.57	1.89	0.76	0.57
keratoacanthoma cell line:HKA-1	10791-110H8	30.89	13.66	1.63	1.30	0.33	3.58	0.65	3.58	5.20	1.95
kidney, adult, pool1	10017-101C8	68.79	53.77	25.53	15.12	13.62	6.71	7.31	1.60	3.60	1.30
kidney, fetal, pool1	10045-101F9	50.72	43.79	38.06	11.11	15.56	6.37	2.69	3.32	3.11	2.12
large cell lung carcinoma cell line:IA-LM	10509-107D5	106.80	62.49	49.85	25.71	26.13	10.08	6.39	1.85	4.40	2.13
large cell lung carcinoma cell line:NCI-H460	10839-111E2	3.32	1.66	0.00	0.00	0.00	0.14	0.00	0.55	0.28	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	30.64	24.59	1.47	1.28	0.55	4.40	4.22	5.69	2.02	2.39
left atrium, adult, donor1	10079-102A7	71.92	7.08	72.47	9.81	17.44	7.08	5.45	2.72	3.81	0.00
left ventricle, adult, donor1	10078-102A6	59.16	12.14	71.30	11.63	16.69	7.08	3.03	3.54	2.02	3.03
leiomyoblastoma cell line:G-402	10721-110A1	53.90	18.88	14.50	5.20	6.57	10.40	4.38	1.64	3.56	1.09
leiomyoma cell line:10964C	10569-108B2	44.55	36.64	98.08	15.09	24.43	3.59	6.11	1.08	1.44	1.44
leiomyoma cell line:15242A	10570-108B3	23.37	23.37	39.67	10.33	7.07	2.17	4.35	0.00	1.09	1.63
leiomyoma cell line:15425	10571-108B4	70.66	53.66	87.90	14.57	30.11	5.58	7.28	3.16	4.86	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	19.05	6.35	19.05	12.70	0.00	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	36.59	12.55	3.14	4.18	1.05	6.27	5.23	1.05	1.05	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	6.14	7.32	1.89	2.95	2.60	1.77	0.59	1.65	0.83	0.83
liposarcoma cell line:KMLS-1	10782-110G8	83.57	65.61	33.74	21.87	19.53	11.72	5.47	2.66	3.12	2.19
liposarcoma cell line:SW 872	10726-110A6	33.99	18.76	4.75	4.14	3.17	6.70	3.90	1.83	1.46	2.07
liver, adult, pool1	10018-101C9	19.77	14.26	27.71	8.27	9.08	2.27	2.11	1.46	1.30	1.30
liver, fetal, pool1	10086-102B5	28.22	5.64	18.81	3.76	3.76	2.82	1.88	0.00	0.94	1.88
locus coeruleus - adult, donor10196	10182-103D2	2.48	1.75	3.94	0.58	1.60	0.58	0.87	1.75	0.29	0.15
locus coeruleus, adult, donor10252	10165-103B3	0.92	3.32	4.61	0.74	2.77	0.00	0.18	1.29	0.18	0.00
locus coeruleus, adult, donor10258	10375-105G6	8.75	0.85	5.92	0.85	1.41	1.41	1.13	0.56	0.56	0.56
locus coeruleus, newborn, donor10223	10362-105F2	11.36	3.79	26.08	5.47	12.62	3.79	0.84	0.42	0.84	0.42
lung adenocarcinoma cell line:A549	10499-107C4	31.97	22.56	3.04	3.74	2.21	4.29	4.29	3.60	0.97	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	14.48	5.52	0.00	0.69	1.38	3.45	2.76	2.76	1.38	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	37.17	12.65	2.64	3.95	2.50	4.22	2.37	2.24	0.66	1.71
lung, adult, pool1	10019-101D1	28.00	16.18	41.46	13.11	15.83	3.43	2.60	1.77	2.95	1.42
lung, fetal, donor1	10068-101I5	63.65	88.19	149.55	15.98	10.56	4.28	14.27	4.00	5.71	2.85
lung, right lower lobe, adult, donor1	10075-102A3	69.19	12.37	81.10	11.91	29.33	6.42	7.79	3.67	7.33	2.29
lymph node, adult, donor1	10077-102A5	28.88	6.63	36.92	7.10	8.99	2.84	2.37	1.89	2.37	0.47
lymphangiectasia cell line:DS-1	10727-110A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	22.94	19.54	1.70	1.70	0.85	1.70	3.40	5.95	1.70	2.55
mature adipocyte, donor1	12231-129F8	9.77	8.44	73.70	24.86	38.18	3.11	0.89	0.89	1.33	0.00
mature adipocyte, donor2	12232-129F9	8.30	9.96	151.29	28.22	54.58	1.25	0.21	1.87	0.00	0.62
mature adipocyte, donor3	12233-129G1	6.40	9.48	74.44	16.83	49.55	0.47	0.71	2.61	0.71	0.00
mature adipocyte, donor4	12234-129G2	5.00	9.48	72.38	22.64	41.06	1.84	0.79	1.32	0.53	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	0.00	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	1.13	3.38	5.64	3.38	1.13	0.00	0.00	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	3.86	4.78	7.36	2.39	3.49	1.10	0.37	2.94	0.37	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	3.18	1.91	6.04	0.32	2.86	2.22	1.59	5.40	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	19.62	12.79	8.53	7.25	6.82	4.26	0.85	0.85	0.00	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	3.04	4.73	5.74	2.19	3.21	1.52	0.68	2.87	0.34	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	4.67	5.94	8.06	2.12	3.82	0.64	1.27	2.33	0.42	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	0.00	0.00	5.78	0.00	0.00	1.93	0.00	3.85	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	186.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	18.66	4.67	7.18	3.23	3.59	3.23	0.36	2.51	2.51	0.72
medulla oblongata - adult, donor10196	10174-103C3	1.95	1.30	8.44	1.95	1.95	1.30	0.65	0.65	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	1.39	2.32	8.05	0.93	2.32	0.31	0.00	0.93	0.15	0.15
medulla oblongata, adult, pool1	10038-101F2	2.04	5.47	5.14	1.14	1.55	0.98	0.24	0.90	0.41	0.57
medulla oblongata, newborn, donor10223	10361-105F1	4.17	1.74	7.99	1.39	2.78	1.74	0.35	0.69	0.69	0.35
medulloblastoma cell line:D283 Med	10838-111E1	1.11	0.44	0.00	0.00	0.00	0.22	0.00	0.00	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	16.02	9.29	0.86	0.73	1.10	2.93	0.61	2.57	0.49	0.73
melanoma cell line:COLO 679	10514-107E1	8.77	4.89	2.16	0.86	0.57	0.57	0.57	1.29	0.57	1.58
melanoma cell line:G-361	10465-106H6	1.09	1.09	0.00	0.00	0.00	0.27	0.00	1.63	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	53.19	68.20	22.43	15.02	11.94	6.33	8.14	5.07	2.71	1.81
merkel cell carcinoma cell line:MKL-1	10843-111E6	9.69	4.41	0.88	0.00	0.00	2.64	1.76	1.76	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	29.29	27.74	2.85	4.41	2.85	4.67	5.96	1.30	1.04	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	33.45	72.73	29.61	12.74	8.29	2.30	7.21	0.92	2.30	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	20.00	38.36	13.09	4.91	4.18	2.36	7.09	0.73	1.09	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	22.78	42.24	35.61	9.94	2.90	2.48	4.14	0.00	0.83	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	10.68	31.89	26.13	9.69	4.64	1.12	4.07	0.70	0.42	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	17.52	41.59	14.83	8.67	5.39	1.54	5.01	0.58	1.73	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	36.09	37.48	50.67	22.90	13.88	4.16	0.69	1.39	1.39	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	40.68	72.77	60.59	17.16	11.84	3.60	11.33	1.72	2.23	1.20
mesenchymal precursor cell - cardiac, donor2	11753-123G7	22.89	56.36	51.07	18.63	12.31	1.84	6.90	1.50	1.61	1.04
mesenchymal precursor cell - cardiac, donor3	11754-123G8	28.25	66.45	24.94	12.07	6.63	2.65	6.10	1.19	1.19	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	36.06	87.78	52.40	19.85	11.48	3.11	8.64	1.89	2.57	1.22
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	38.70	80.09	19.49	9.25	3.84	3.70	11.95	1.56	3.27	1.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	140.96	88.60	77.07	24.04	23.71	18.77	12.84	3.62	5.27	2.96
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	37.91	68.77	8.99	5.26	1.66	4.84	13.84	1.66	2.91	1.25
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	87.97	99.84	23.39	18.50	16.06	10.12	10.82	3.49	5.93	2.09
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	28.99	64.92	10.41	4.90	3.27	3.47	9.19	1.63	2.04	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	77.64	67.58	34.51	13.66	13.30	9.71	8.27	0.72	3.59	2.16
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	15.72	29.48	1.97	1.34	0.52	1.55	3.93	0.72	1.55	1.45
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	31.46	24.17	7.98	2.96	3.19	3.42	2.74	0.91	2.28	1.82
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	21.40	84.75	36.08	16.78	5.45	2.52	9.23	0.84	1.68	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	48.57	98.48	36.46	12.85	6.28	4.48	15.09	1.49	2.54	1.49
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	20.83	51.21	5.16	3.33	1.75	1.93	5.78	1.66	1.14	0.70
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	81.36	85.41	24.67	11.78	8.10	9.94	5.89	2.58	5.15	1.84
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	66.96	61.52	31.48	13.45	10.87	9.73	9.44	2.29	4.29	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	15.16	23.16	2.53	2.95	0.84	1.26	2.11	1.68	0.00	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	30.60	21.46	31.97	16.90	10.96	2.28	3.20	0.46	2.74	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	37.60	30.44	30.95	23.28	16.11	4.60	3.58	1.79	2.05	2.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	36.65	31.41	41.62	22.77	14.66	2.62	2.62	2.62	3.14	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	37.28	33.89	36.05	19.72	17.87	3.08	4.93	2.16	4.01	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	36.72	30.13	30.13	21.18	15.30	3.53	4.71	1.41	1.18	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	34.52	31.14	31.81	19.97	18.28	2.03	4.06	2.37	2.37	2.03
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	36.15	29.87	32.22	20.43	16.50	2.75	4.72	3.54	3.14	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	44.49	28.73	28.73	18.54	16.22	3.71	5.10	0.93	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	48.30	48.30	0.00	0.00	0.00	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	51.92	31.73	39.22	22.21	23.07	3.46	4.33	3.17	4.61	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	37.70	32.80	33.91	22.09	20.30	1.56	2.90	1.34	1.34	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	34.13	33.89	33.65	17.31	19.95	4.09	3.36	2.64	2.16	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	55.73	40.33	43.27	38.13	23.47	2.20	9.53	2.93	4.40	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	34.57	27.52	30.21	20.14	17.79	2.35	4.36	1.34	1.68	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	37.25	33.98	36.03	20.06	16.78	5.32	2.87	1.64	1.64	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	38.23	37.37	30.50	16.32	18.04	3.87	3.87	3.01	2.58	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	51.95	49.22	35.55	16.41	8.20	0.00	5.47	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	25.82	67.14	20.66	36.15	0.00	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	26.96	29.56	38.97	20.46	15.91	2.27	1.95	0.97	0.97	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	21.82	24.73	52.38	27.64	18.91	1.45	4.36	2.91	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	37.32	27.19	47.44	20.79	19.19	2.67	3.20	1.07	3.73	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	18.81	32.71	31.08	21.26	13.90	3.27	4.09	1.64	3.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	34.21	27.60	38.09	18.66	15.16	1.94	3.89	1.94	1.94	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	27.28	39.88	31.48	18.89	23.09	2.10	2.10	2.10	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	29.80	26.82	49.67	13.91	12.92	0.99	3.97	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	38.14	23.84	28.60	9.53	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	29.65	43.88	43.29	17.79	16.01	2.37	4.74	1.19	1.78	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	21.93	43.86	41.43	20.71	17.06	2.44	0.00	0.00	3.66	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	27.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	31.67	31.04	40.54	24.70	21.54	1.27	5.07	3.17	3.17	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	36.21	25.87	17.59	9.66	8.62	2.07	2.41	0.34	1.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	21.49	23.64	17.19	12.90	6.45	0.00	4.30	0.00	4.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	11.98	35.93	7.98	7.98	3.99	0.00	3.99	7.98	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	10.33	6.89	3.44	3.44	6.89	0.00	0.00	6.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	35.86	18.74	14.67	8.15	7.74	1.63	1.63	2.85	3.67	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	36.54	18.27	15.89	6.36	3.97	0.79	3.18	2.38	2.38	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	25.35	18.28	9.43	7.07	6.48	2.95	2.95	1.77	3.54	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	29.30	15.90	15.27	8.73	9.97	2.81	0.94	3.43	2.18	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	34.75	18.71	24.06	14.70	10.69	1.34	2.67	2.67	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	17.74	13.01	33.11	7.10	15.37	1.18	1.18	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	20.54	7.70	33.38	20.54	25.68	5.14	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	22.03	9.64	19.28	13.77	23.41	2.07	2.07	1.38	2.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	18.80	17.81	18.31	5.94	11.38	0.49	1.48	1.48	0.99	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	6.73	4.49	21.31	7.85	7.85	0.00	0.00	0.00	4.49	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	14.63	10.81	24.81	10.18	15.27	0.64	0.64	1.91	1.27	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	4.03	3.63	5.64	4.84	3.22	0.81	0.81	1.21	0.40	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	6.54	0.00	4.36	0.00	4.36	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	0.00	7.60	2.53	1.27	3.80	1.27	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	7.28	4.25	7.89	3.03	4.86	1.21	0.61	1.21	0.61	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	9.04	13.56	4.52	4.52	0.00	4.52	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	7.41	3.29	12.36	2.47	6.59	1.65	0.00	1.65	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	33.73	12.70	26.19	16.47	16.27	3.17	2.58	0.99	2.78	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	30.18	12.01	14.60	12.01	16.22	4.54	0.97	1.62	0.97	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	30.56	17.32	9.17	11.20	10.19	1.02	1.02	1.02	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	20.89	5.42	4.64	0.77	0.77	4.64	0.00	1.55	2.32	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	36.38	20.08	1.65	2.83	1.18	6.38	4.49	5.43	4.02	1.18
mesothelioma cell line:ACC-MESO-4	10494-107B8	5.56	3.24	0.00	0.23	0.00	1.85	1.16	0.23	0.93	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	25.64	25.64	4.27	4.27	4.27	0.00	4.27	0.00	4.27	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	69.46	18.91	9.04	5.86	4.21	5.24	2.98	2.67	4.21	1.85
mesothelioma cell line:Mero-25	10850-111F4	5.90	5.67	0.45	0.00	0.00	0.45	1.13	0.68	0.45	0.45
mesothelioma cell line:Mero-41	10851-111F5	19.31	23.96	8.31	4.89	1.96	1.96	2.20	1.96	0.73	0.49
mesothelioma cell line:Mero-48a	10852-111F6	2.66	2.44	0.00	0.66	0.66	0.44	0.22	0.44	0.00	0.66
mesothelioma cell line:Mero-82	10853-111F7	16.56	13.40	3.15	1.58	2.10	1.31	2.37	2.10	0.53	0.26
mesothelioma cell line:Mero-83	10854-111F8	28.60	21.96	16.85	8.17	6.30	3.06	3.74	1.19	1.70	1.36
mesothelioma cell line:Mero-84	10855-111F9	7.84	10.87	0.25	0.25	0.25	1.26	1.52	0.51	0.51	0.76
mesothelioma cell line:Mero-95	10856-111G1	13.25	12.01	1.45	1.24	0.83	2.48	1.04	1.86	1.04	1.24
mesothelioma cell line:NCI-H2052	10847-111F1	11.60	12.92	2.65	1.66	1.49	0.66	2.32	0.33	0.33	0.33
mesothelioma cell line:NCI-H226	10846-111E9	4.16	6.70	0.72	0.36	0.36	0.54	0.72	0.54	0.36	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	57.57	62.69	29.89	13.15	10.93	3.07	9.40	3.76	3.25	1.88
mesothelioma cell line:NCI-H28	10845-111E8	6.62	13.74	1.27	2.29	1.78	1.27	0.25	0.76	0.00	0.00
mesothelioma cell line:No36	10857-111G2	0.65	0.33	0.00	0.00	0.33	0.65	0.00	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	16.53	11.38	2.98	1.08	0.81	0.54	2.44	1.08	1.90	0.54
migratory langerhans cells, donor1	11901-125F2	0.00	0.19	0.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	0.00	0.00	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	0.00	0.00	0.00	0.18	0.00	0.00	0.00	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	3.92	11.10	0.65	0.98	0.98	0.98	0.65	1.96	0.33	1.96
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	16.53	12.50	1.70	2.33	1.91	9.11	1.91	2.54	0.21	1.91
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	202.71	58.97	9.68	9.91	7.60	32.25	10.60	10.14	9.91	4.38
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	0.00	0.00	0.00	0.00	0.00	0.00	0.19	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	8.69	7.76	2.22	1.11	0.55	1.85	0.55	2.59	0.37	1.11
myeloma cell line:PCM6	10474-106I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	171.97	48.70	3.04	3.04	2.54	24.35	11.16	9.13	11.67	10.15
myxofibrosarcoma cell line:NMFH-1	10684-109E9	37.85	39.62	31.19	19.42	19.61	3.73	7.06	3.33	0.98	1.96
nasal epithelial cells, donor1, tech_rep1	12226-129F3	1.11	3.23	0.22	0.22	0.00	0.11	0.33	0.89	0.56	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	1.99	1.76	0.15	0.22	0.00	0.15	0.07	0.81	0.07	0.07
nasal epithelial cells, donor2	12227-129F4	20.42	23.18	0.55	3.86	0.55	0.55	0.00	1.10	0.55	1.66
neuroblastoma cell line:CHP-134	10508-107D4	26.00	16.33	1.38	0.92	0.92	5.06	3.22	1.61	1.61	0.46
neuroblastoma cell line:NB-1	10539-107G8	30.68	26.38	3.37	2.06	3.18	9.17	1.87	1.12	2.25	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	33.74	27.42	3.16	1.69	0.21	5.27	6.75	2.11	1.27	0.42
neuroblastoma cell line:NH-12	10555-107I6	8.76	7.83	0.00	0.93	0.75	2.42	1.12	0.93	0.19	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	14.95	7.35	0.71	0.24	0.00	3.32	2.61	1.19	1.19	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	15.05	6.97	0.79	0.79	0.95	1.74	0.95	1.11	0.79	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	7.45	6.44	1.21	0.20	0.60	2.01	0.81	0.60	1.01	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	6.99	1.27	0.64	0.00	0.00	1.91	1.91	1.27	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	72.66	33.27	15.97	5.59	7.19	15.44	5.06	2.13	4.52	1.60
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	2.20	2.88	0.00	0.00	0.00	0.17	0.00	0.68	0.17	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	12.01	24.82	2.40	9.61	0.00	3.20	0.00	1.60	4.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	56.43	36.55	7.69	5.13	6.09	11.22	1.92	2.24	1.60	1.92
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	0.00	0.26	0.53	0.26	0.00	0.00	0.00	0.00	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	3.56	8.25	6.47	1.69	0.94	0.75	0.37	2.16	0.66	0.56
occipital cortex - adult, donor10196	10172-103C1	0.00	0.00	8.24	2.06	2.06	4.12	2.06	4.12	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	1.61	5.90	9.93	3.49	4.29	0.81	0.54	1.61	0.27	0.00
occipital cortex, newborn, donor10223	10355-105E4	9.46	4.00	8.01	1.82	3.28	2.18	0.36	0.73	0.73	0.36
occipital lobe, adult, donor1	10076-102A4	8.40	3.94	4.72	0.52	1.31	0.79	0.52	1.84	0.79	0.52
occipital lobe, fetal, donor1	10073-102A1	55.78	14.59	20.17	9.01	12.87	14.59	3.86	9.87	3.00	1.29
occipital pole, adult, pool1	10036-101E9	1.10	4.81	2.37	1.42	0.63	0.39	0.32	1.66	0.08	0.39
olfactory region, adult	10195-103E6	3.82	3.44	1.72	0.38	0.57	0.96	0.00	2.29	0.38	0.00
optic nerve, donor1	10277-104E7	6.00	0.00	2.00	2.00	2.00	2.00	2.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	0.23	1.37	0.11	0.46	0.00	0.00	0.00	0.46	0.00	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	6.05	5.77	0.14	0.41	0.14	1.24	0.27	2.06	0.41	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	18.96	10.16	1.19	0.85	0.34	1.86	0.68	0.85	1.19	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	3.93	5.43	0.23	0.35	0.12	0.35	0.35	1.16	0.00	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	25.28	22.64	7.35	7.94	5.00	2.06	5.88	4.12	2.06	2.65
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	227.04	56.06	15.88	7.47	6.54	24.29	13.08	19.62	6.54	8.41
osteosarcoma cell line:HS-Os-1	10558-107I9	4.67	3.39	0.64	0.42	0.21	0.42	0.64	1.48	0.21	0.85
ovary, adult, pool1	10020-101D2	36.43	19.30	24.72	8.39	8.56	3.14	1.57	2.97	1.66	1.40
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	42.35	17.97	5.13	4.40	4.03	13.20	4.22	3.30	2.20	2.75
pancreas, adult, donor1	10049-101G4	14.11	11.29	9.41	4.70	6.58	0.94	0.94	0.00	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	3.58	3.92	1.87	1.19	0.68	1.02	0.17	0.85	0.00	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	68.88	33.61	2.32	5.13	4.31	7.62	3.15	5.80	2.65	2.81
paracentral gyrus, adult, pool1	10035-101E8	2.93	8.69	4.85	2.20	1.46	1.01	0.37	1.56	0.73	0.55
parietal cortex, adult, donor10258	10373-105G4	0.73	12.48	1.47	2.20	0.73	1.47	0.73	2.20	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	3.76	4.70	11.29	2.82	1.88	1.88	0.00	2.82	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	2.00	7.98	7.41	2.85	3.14	1.71	0.29	4.56	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	4.23	7.05	5.02	1.32	0.97	1.06	0.44	2.20	1.06	0.53
parietal lobe, fetal, donor1	10072-101I9	45.58	14.55	21.34	5.82	9.70	10.67	2.91	5.82	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	13.83	5.98	8.97	2.62	4.11	3.36	0.00	0.75	1.12	1.50
parotid gland, adult	10199-103F1	1.85	3.08	7.40	0.62	2.47	1.23	0.00	0.62	0.00	0.00
penis, adult	10200-103F2	15.58	17.72	38.13	6.45	10.74	0.54	2.69	2.69	2.69	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	2.05	0.19	0.00	0.00	0.19	0.19	0.19	0.00	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	4.23	3.64	1.17	1.02	0.15	1.17	0.44	1.60	0.44	0.87
pineal gland - adult, donor10196	10179-103C8	3.87	0.65	7.74	0.00	0.00	0.00	0.00	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	4.15	4.15	11.25	0.59	5.92	1.18	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	5.64	0.63	8.15	2.51	0.00	0.00	0.00	0.00	1.25	0.00
pituitary gland - adult, donor10196	10180-103C9	4.05	3.04	7.08	0.00	3.04	1.01	0.00	2.02	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	5.21	11.47	16.16	3.65	2.08	3.65	1.04	1.56	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	2.55	1.70	8.51	3.40	1.70	0.85	0.00	1.70	0.00	0.00
placenta, adult, pool1	10021-101D3	36.34	31.82	56.65	11.40	14.94	4.30	1.94	2.37	2.90	1.08
plasma cell leukemia cell line:ARH-77	10840-111E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	57.12	36.58	6.69	4.82	4.98	7.16	5.76	0.93	2.49	0.62
pons, adult, pool1	10033-101E6	1.81	4.99	4.56	0.69	1.12	0.86	0.34	1.81	0.17	0.09
postcentral gyrus, adult, pool1	10032-101E5	3.66	7.15	3.05	1.13	1.22	1.13	0.61	2.27	0.35	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	0.00	0.00	2.09	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	41.22	32.19	2.91	2.77	1.31	5.24	4.52	4.22	1.46	1.46
prostate cancer cell line:PC-3	10439-106E7	415.46	141.21	159.00	44.83	59.17	53.00	43.56	8.71	13.98	4.72
prostate, adult, pool1	10022-101D4	26.12	15.33	34.92	8.98	10.79	3.45	1.63	3.45	1.27	1.09
putamen, adult, donor10196	10176-103C5	2.36	5.90	5.43	0.94	3.30	0.24	0.94	3.30	0.00	0.94
putamen, adult, donor10252	10152-102I8	0.00	5.88	5.88	1.96	0.00	0.00	0.00	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	0.00	1.09	0.00	2.19	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	1.45	2.17	2.90	0.48	1.45	0.00	0.00	0.72	0.72	0.24
putamen, newborn, donor10223	10365-105F5	11.99	9.00	11.24	4.50	9.00	1.50	0.00	3.75	1.50	0.00
rectal cancer cell line:TT1TKB	10469-106I1	0.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	72.33	30.60	65.38	11.13	16.69	9.74	4.17	5.56	1.39	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	59.78	46.43	10.39	13.14	8.06	4.88	4.88	5.94	1.48	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	14.08	21.54	3.31	5.38	3.31	3.31	2.90	1.66	1.24	1.24
retina, adult, pool1	10030-101E3	28.63	25.84	37.08	11.33	12.42	3.08	2.78	1.89	1.79	1.79
retinoblastoma cell line:Y79	10475-106I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	46.97	44.26	3.69	2.34	1.48	10.70	3.32	3.81	4.43	1.97
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	0.28	0.00	0.00	0.00	0.00	0.00	0.28	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	96.25	27.28	1.52	3.79	3.79	13.64	7.58	3.79	4.55	3.79
salivary acinar cells, donor1	11771-123I7	15.86	12.30	2.59	2.43	3.40	2.10	1.13	1.94	0.97	0.97
salivary acinar cells, donor2	11772-123I8	15.28	12.12	4.54	3.03	3.44	1.10	0.96	0.69	1.10	0.96
salivary acinar cells, donor3	11773-123I9	25.82	2.65	0.66	3.97	2.65	0.00	1.99	0.66	0.66	0.66
salivary gland, adult, pool1	10093-102C3	1.72	6.29	18.30	1.72	1.72	0.57	0.57	1.14	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	57.08	48.39	26.90	11.04	9.86	7.00	4.72	3.96	2.53	2.53
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	69.94	36.68	26.33	9.40	10.11	9.05	6.11	4.35	3.41	4.11
seminal vesicle, adult	10201-103F3	21.69	25.40	41.27	18.52	12.17	5.29	2.65	4.76	3.70	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	6.56	5.83	0.49	1.46	0.49	0.97	0.73	1.94	0.49	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	16.36	19.38	2.52	3.77	2.77	1.01	1.26	1.01	1.51	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	67.24	37.13	9.03	8.03	3.01	6.02	5.02	4.01	1.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	0.00	0.67	0.00	0.13	0.00	0.00	0.00	0.27	0.00	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	4.64	8.84	0.88	0.44	0.55	0.55	0.22	0.55	0.33	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	0.13	1.03	0.00	0.00	0.00	0.00	0.13	0.39	0.13	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	17.02	5.67	24.83	4.97	7.80	1.42	2.84	0.71	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	12.95	10.07	43.78	8.04	12.23	0.84	0.60	1.32	0.96	0.12
skeletal muscle, fetal, donor1	10066-101I3	31.16	4.02	62.31	8.04	13.07	8.04	2.01	1.01	0.00	1.01
skin, adult, donor1	10074-102A2	20.36	6.79	54.28	13.57	0.00	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	44.19	31.56	77.01	12.62	25.25	6.94	5.68	3.16	2.52	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	2.33	2.33	0.67	0.33	0.00	0.33	1.00	2.00	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	7.88	5.04	0.00	0.63	0.63	1.58	0.00	0.63	0.63	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	1.16	1.35	0.00	0.00	0.39	0.00	0.00	1.54	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	0.33	0.00	0.00	0.00	0.00	0.16	0.00	0.16	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	0.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	48.16	46.42	6.97	5.01	3.27	6.76	6.97	1.96	1.31	1.31
small intestine, adult, pool1	10024-101D6	17.32	11.82	26.87	3.70	6.81	2.27	1.07	3.46	1.55	0.60
small intestine, fetal, donor1	10064-101I1	39.07	9.83	23.34	3.69	6.14	5.16	2.70	1.72	2.21	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	2.05	2.56	1.03	1.03	0.00	1.03	0.00	3.08	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	11.89	7.75	15.51	4.14	4.65	1.03	0.52	2.58	0.52	0.26
somatostatinoma cell line:QGP-1	10781-110G7	5.09	2.95	0.27	1.34	0.54	1.61	0.00	2.41	0.54	0.27
spinal cord - adult, donor10196	10181-103D1	13.53	2.75	3.90	1.15	1.61	3.44	2.06	1.61	0.92	0.92
spinal cord, adult, donor10252	10159-103A6	3.94	2.37	5.13	0.79	1.97	0.00	0.79	0.79	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	2.77	6.23	7.61	1.38	1.38	1.38	0.00	1.38	0.00	1.38
spinal cord, fetal, donor1	10056-101H2	31.10	25.61	27.44	6.10	3.66	4.88	1.83	3.05	0.61	1.22
spinal cord, newborn, donor10223	10359-105E8	12.40	3.21	12.86	3.67	4.59	1.38	0.00	1.84	0.46	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	48.84	23.30	9.41	7.62	6.12	8.21	3.29	2.39	2.39	1.79
spleen, adult, pool1	10025-101D7	36.12	20.71	46.70	12.11	17.84	5.84	2.97	2.53	4.30	2.20
spleen, fetal, pool1	10044-101F8	49.18	43.78	69.13	18.83	24.07	5.96	3.89	3.50	4.21	3.10
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	1.14	2.47	0.38	0.00	0.19	0.57	0.19	1.33	0.38	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	5.24	11.18	8.04	2.10	3.49	0.00	0.35	3.15	0.35	1.75
squamous cell carcinoma cell line:T3M-5	10616-108G4	64.11	32.84	5.47	4.30	1.17	12.51	4.30	3.91	1.95	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	17.33	22.06	3.49	6.98	4.50	2.14	2.81	4.84	0.68	1.46
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	0.85	0.42	0.00	0.00	0.00	0.00	0.00	0.42	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	7.62	1.27	1.69	0.00	0.42	0.85	0.42	0.85	0.42	0.00
stomach, fetal, donor1	10062-101H8	82.23	7.48	13.88	4.27	2.14	11.75	4.27	5.34	5.34	1.07
submaxillary gland, adult	10202-103F4	4.56	4.56	11.96	2.85	3.42	0.57	1.71	0.57	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	1.45	2.08	7.69	1.25	1.87	0.21	0.00	0.42	0.21	0.21
substantia nigra, adult, donor10258	10371-105G2	1.55	1.03	3.10	0.52	1.55	1.55	0.00	4.66	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	16.96	2.83	12.01	3.53	3.53	0.71	1.41	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	30.72	38.52	14.90	11.46	10.32	6.65	0.92	0.92	2.52	0.23
temporal lobe, adult, pool1	10031-101E4	2.97	6.27	2.97	1.10	1.44	0.76	0.59	1.27	0.34	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	32.76	17.81	12.11	7.83	12.11	9.97	2.85	4.27	2.85	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	17.58	22.86	9.23	7.47	6.59	5.71	1.32	2.64	2.20	0.44
tenocyte, donor1	11763-123H8	25.48	32.12	14.66	11.87	6.28	2.79	1.40	2.09	2.44	1.05
tenocyte, donor2	11765-123I1	12.59	21.75	14.50	11.45	4.20	1.14	1.91	1.14	1.14	0.38
tenocyte, donor3	11768-123I4	27.06	33.73	18.53	10.75	5.93	1.11	2.59	2.22	0.74	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	5.27	7.65	0.85	1.19	1.19	1.53	0.34	2.21	0.51	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	40.08	24.82	4.47	4.47	2.62	7.71	5.24	2.31	2.77	0.92
teratocarcinoma cell line:PA-1	10807-111A6	1.86	1.70	0.31	0.00	0.00	0.15	0.00	0.62	0.15	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	0.13	0.00	0.25	0.00	0.13	0.00	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	0.00	0.00	0.00	0.00	0.00	0.38	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	0.22	0.65	0.22	0.11	0.11	0.00	0.00	0.44	0.11	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	0.33	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	32.64	12.46	32.53	6.87	9.23	3.44	3.11	2.68	1.61	1.61
testis, adult, pool2	10096-102C6	10.83	8.57	4.96	1.35	2.71	0.45	0.90	0.00	0.90	0.90
thalamus - adult, donor10196	10168-103B6	8.83	2.21	9.94	1.10	2.21	3.31	0.00	4.42	0.00	0.00
thalamus, adult, donor10252	10154-103A1	1.72	2.97	7.03	1.56	1.56	0.47	0.94	0.47	0.00	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	0.00	1.54	7.70	1.54	0.00	0.00	0.00	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	5.60	1.98	5.43	1.32	0.82	0.99	0.82	1.65	0.82	0.99
thalamus, newborn, donor10223	10366-105F6	17.83	4.03	5.18	4.03	2.30	2.30	2.30	2.30	0.58	0.58
throat, adult	10209-103G2	10.49	10.99	33.21	5.49	11.48	0.75	1.25	2.25	1.00	1.00
throat, fetal, donor1	10061-101H7	72.52	19.81	59.11	9.45	15.84	14.02	4.88	2.13	3.66	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	0.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
thymus, adult, pool1	10027-101D9	5.57	2.68	12.53	0.99	2.68	0.50	0.40	0.60	1.09	0.00
thymus, fetal, pool1	10043-101F7	11.95	6.75	23.48	3.22	5.09	2.18	0.83	1.04	1.04	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	45.47	19.01	5.85	4.12	2.13	3.59	5.58	3.86	2.13	2.79
thyroid carcinoma cell line:TCO-1	10783-110G9	18.02	13.83	3.77	3.91	3.21	3.91	1.82	3.49	1.12	0.56
thyroid, adult, pool1	10028-101E1	19.04	11.57	34.71	9.61	12.41	1.87	0.84	1.31	1.77	0.47
thyroid, fetal, donor1	10060-101H6	50.89	12.39	65.65	13.18	20.30	8.17	5.27	3.16	1.58	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	46.19	12.32	46.19	15.40	24.64	6.16	3.08	0.00	3.08	0.00
tongue, adult	10203-103F5	16.51	13.49	37.68	5.81	9.77	0.93	2.33	0.47	1.16	0.23
tongue, fetal, donor1	10059-101H5	36.65	9.46	61.48	5.12	14.98	7.49	2.36	1.97	2.76	0.79
tonsil, adult, pool1	10047-101G2	10.22	6.51	12.22	3.11	4.31	1.10	1.00	0.70	1.00	0.20
trachea, adult, pool1	10029-101E2	13.33	8.83	33.54	5.97	10.72	1.39	0.90	0.98	0.65	0.41
trachea, fetal, donor1	10058-101H4	61.55	23.08	48.86	9.23	13.85	10.00	6.16	2.31	3.08	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	89.99	41.80	23.74	13.46	12.05	11.69	12.40	2.48	2.13	3.54
transitional-cell carcinoma cell line:5637	10418-106C4	34.75	19.25	2.43	1.62	2.23	4.56	1.82	1.32	1.42	0.81
transitional-cell carcinoma cell line:JMSU1	10492-107B6	20.53	13.01	3.13	3.60	2.04	1.57	2.04	1.57	2.04	0.63
tridermal teratoma cell line:HGRT	10694-109G1	226.40	28.54	3.81	9.51	0.00	43.76	43.76	1.90	13.32	5.71
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	53.25	34.96	7.11	8.21	8.63	5.93	2.62	2.79	2.79	3.13
umbilical cord, fetal, donor1	10057-101H3	18.78	14.61	22.95	10.43	6.26	0.00	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	24.23	43.17	60.06	6.65	4.78	5.46	6.14	3.24	1.19	1.88
uterus, fetal, donor1	10055-101H1	93.17	46.59	35.83	9.21	14.85	14.33	8.70	3.58	2.56	3.58
vagina, adult	10204-103F6	5.17	7.11	52.99	3.88	12.28	0.65	0.65	1.94	0.00	0.65
vein, adult	10191-103E2	20.39	12.06	34.85	4.82	11.62	2.41	2.63	1.32	0.88	1.32
xeroderma pigentosum b cell line:XPL 17	10563-108A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Property "Nearest transcripts" (as page type) with input value "BX648250:25 ENST00000432372.6:-171 BX648025:-171 ENST00000374867.7:232 NM_003873.7:232 NM_001330068.2:232 NM_001244972.2:232 NM_001244973.2:232 NR_045259.2:232 NM_001024628.3:232 NM_001024629.3:232 ENST00000374822.8:257 BC007533:257 ENST00000374875.5:263 AL833608:263 AK292822:328 BX510902:357 AB209641:368 ENST00000374821.9:377 ENST00000374816.7:377 BC007737:377 AF268691:377" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.